BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, Richter C, Zips D, Bortfeld T. Radiation oncology in the era of precision medicine. Nat Rev Cancer 2016;16:234-49. [PMID: 27009394 DOI: 10.1038/nrc.2016.18] [Cited by in Crossref: 464] [Cited by in F6Publishing: 484] [Article Influence: 66.3] [Reference Citation Analysis]
Number Citing Articles
1 Price JM, Prabhakaran A, West CML. Predicting tumour radiosensitivity to deliver precision radiotherapy. Nat Rev Clin Oncol 2023;20:83-98. [PMID: 36477705 DOI: 10.1038/s41571-022-00709-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Starke S, Zwanenburg A, Leger K, Zöphel K, Kotzerke J, Krause M, Baumann M, Troost EGC, Löck S. Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction. Cancers 2023;15:673. [DOI: 10.3390/cancers15030673] [Reference Citation Analysis]
3 Chiu LY, Sun Q, Zenke FT, Blaukat A, Vassilev LT. Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death. Aging (Albany NY) 2023;15. [PMID: 36656721 DOI: 10.18632/aging.204487] [Reference Citation Analysis]
4 Freitas SC, Sanderson D, Caspani S, Magalhães R, Cortés-Llanos B, Granja A, Reis S, Belo JH, Azevedo J, Gómez-Gaviro MV, Sousa CT. New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy. Cancers (Basel) 2023;15. [PMID: 36672333 DOI: 10.3390/cancers15020383] [Reference Citation Analysis]
5 Chen CJ, Hu YC, Chien Y, Huang WC, Wu CS, Tsai CY, Lin YH, Lee MS, Chien CS, Yang YP, Lee MC, Tseng CC, Chi HC. Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma. Oxid Med Cell Longev 2023;2023:8753309. [PMID: 36644580 DOI: 10.1155/2023/8753309] [Reference Citation Analysis]
6 Hoque S, Dhar R, Kar R, Mukherjee S, Mukherjee D, Mukerjee N, Nag S, Tomar N, Mallik S. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance. Biomarkers 2023;:1-13. [PMID: 36503350 DOI: 10.1080/1354750X.2022.2157875] [Reference Citation Analysis]
7 Offersen BV, Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Thwaites DI, van der Kogel AJ, van der Heide U, Valentini V, Overgaard J, Baumann M. The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice. Radiother Oncol 2022;179:109446. [PMID: 36566990 DOI: 10.1016/j.radonc.2022.109446] [Reference Citation Analysis]
8 Köksal M, Streppel R, Hauser S, Abramian A, Kaiser C, Gonzalez-carmona M, Feldmann G, Schäfer N, Koob S, Banat M, Hamed M, Giordano FA, Schmeel LC. Impact of patient nationality on the severity of early side effects after radiotherapy. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04505-0] [Reference Citation Analysis]
9 Hong JA, Vikram B, Buchsbaum J, Capala J, Livinski A, Teicher B, Prasanna P, Ahmed MM, Obcemea C, Coleman CN, Graham Espey M. The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation. Radiat Res 2022;198:625-31. [PMID: 35976726 DOI: 10.1667/RADE-22-00077.1] [Reference Citation Analysis]
10 Zhu S, Wang Y, Tang J, Cao M. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment. Front Immunol 2022;13:1074477. [PMID: 36532071 DOI: 10.3389/fimmu.2022.1074477] [Reference Citation Analysis]
11 Li Y, Huang C, Xu Y. Colon cancer exosome-derived biomimetic nanoplatform for curcumin-mediated sonodynamic therapy and calcium overload. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1069676] [Reference Citation Analysis]
12 Rühle A, Todorovic J, Spohn SSK, Gkika E, Becker C, Knopf A, Zamboglou C, Sprave T, Werner M, Grosu A, Kayser G, Nicolay NH. Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy. Radiat Oncol 2022;17:181. [DOI: 10.1186/s13014-022-02153-9] [Reference Citation Analysis]
13 Zhou J, Belina M, Jia S, Xue X, Hao X, Ren X, Slavíček P. Ultrafast Charge and Proton Transfer in Doubly Ionized Ammonia Dimers. J Phys Chem Lett 2022. [DOI: 10.1021/acs.jpclett.2c02560] [Reference Citation Analysis]
14 Schauer J, Wieser H, Huang Y, Ruser H, Lascaud J, Würl M, Chmyrov A, Vidal M, Herault J, Ntziachristos V, Assmann W, Parodi K, Dollinger G. Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.925542] [Reference Citation Analysis]
15 Fiddimore E, Harrop E, Nelson A, Sivell S. “I don’t want to hear statistics, I want real life stories”: Systematic review and thematic synthesis of patient and caregiver experiences of Proton Beam Therapy. Journal of Psychosocial Oncology 2022. [DOI: 10.1080/07347332.2022.2136997] [Reference Citation Analysis]
16 Chai R, Yu L, Dong C, Yin Y, Wang S, Chen Y, Zhang Q. Oxygen-evolving photosynthetic cyanobacteria for 2D bismuthene radiosensitizer-enhanced cancer radiotherapy. Bioact Mater 2022;17:276-88. [PMID: 35386463 DOI: 10.1016/j.bioactmat.2022.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sun H, Cai H, Xu C, Zhai H, Lux F, Xie Y, Feng L, Du L, Liu Y, Sun X, Wang Q, Song H, He N, Zhang M, Ji K, Wang J, Gu Y, Leduc G, Doussineau T, Wang Y, Liu Q, Tillement O. AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway. J Nanobiotechnology 2022;20:449. [PMID: 36242003 DOI: 10.1186/s12951-022-01654-9] [Reference Citation Analysis]
18 Luhts BV. Early and late radiation complications after application of preoperative radiation therapy in complex treatment of cancer recti. KH 2022;89:8-10. [DOI: 10.26779/2522-1396.2022.1-2.08] [Reference Citation Analysis]
19 Rabasco Meneghetti A, Zwanenburg A, Linge A, Lohaus F, Grosser M, Baretton GB, Kalinauskaite G, Tinhofer I, Guberina M, Stuschke M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Böke S, Zips D, Troost EGC, Krause M, Baumann M, Löck S. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC. Sci Rep 2022;12:16755. [PMID: 36202941 DOI: 10.1038/s41598-022-21159-7] [Reference Citation Analysis]
20 Thorwarth D. Clinical use of positron emission tomography for radiotherapy planning – Medical physics considerations. Zeitschrift für Medizinische Physik 2022. [DOI: 10.1016/j.zemedi.2022.09.001] [Reference Citation Analysis]
21 Pan P, Dong X, Chen Y, Ye JJ, Sun YX, Zhang XZ. A heterogenic membrane-based biomimetic hybrid nanoplatform for combining radiotherapy and immunotherapy against breast cancer. Biomaterials 2022;289:121810. [PMID: 36152517 DOI: 10.1016/j.biomaterials.2022.121810] [Reference Citation Analysis]
22 Grassilli S, Bertagnolo V, Brugnoli F. Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches. Diagnostics 2022;12:2139. [DOI: 10.3390/diagnostics12092139] [Reference Citation Analysis]
23 Garcia-Peiro JI, Bonet-Aleta J, Santamaria J, Hueso JL. Platinum nanoplatforms: classic catalysts claiming a prominent role in cancer therapy. Chem Soc Rev 2022;51:7662-81. [PMID: 35983786 DOI: 10.1039/d2cs00518b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Kundrát P, Pachnerová Brabcová K, Jelínek Michaelidesová A, Zahradníček O, Danilová I, Štěpán V, Jamborová Z, Davídková M. BORON-ENHANCED BIOLOGICAL EFFECTIVENESS OF PROTON IRRADIATION: STRATEGY TO ASSESS THE UNDERPINNING MECHANISM. Radiat Prot Dosimetry 2022;198:527-31. [PMID: 36005957 DOI: 10.1093/rpd/ncac093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Labiano S, Serrano-Mendioroz I, Rodriguez-Ruiz ME. Flow cytometry-assisted quantification of immune cells infiltrating irradiated tumors in mice. Methods Cell Biol 2023;174:1-16. [PMID: 36710044 DOI: 10.1016/bs.mcb.2022.07.005] [Reference Citation Analysis]
26 Deichaite I, Hopper A, Krockenberger L, Sears TJ, Sutton L, Ray X, Sharabi A, Navon A, Sanghvi P, Carter H, Moiseenko V. Germline genetic biomarkers to stratify patients for personalized radiation treatment. J Transl Med 2022;20:360. [PMID: 35962345 DOI: 10.1186/s12967-022-03561-x] [Reference Citation Analysis]
27 Naumann M, Czempiel T, Lößner AJ, Pape K, Beyreuther E, Löck S, Drukewitz S, Hennig A, von Neubeck C, Klink B, Krause M, William D, Stange DE, Bütof R, Dietrich A. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids. Cancers 2022;14:3781. [DOI: 10.3390/cancers14153781] [Reference Citation Analysis]
28 Rumley CN, Hansen CR, Jameson MG, Trada Y, Johansen J, Gyldenkerne N, Eriksen JG, Aly F, Christensen RL, Lee M, Brink C, Holloway L. Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.08.005] [Reference Citation Analysis]
29 Trigilio A, De Gregorio A, Fischetti M, Franciosini G, Garbini M, Lippa G, Magi M, Marafini M, Muscato A, Patera V, Sarti A, Schiavi A, Sciubba A, Toppi M, Traini G, De Simoni M. The FlashDC project: Development of a beam monitor for FLASH radiotherapy. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2022. [DOI: 10.1016/j.nima.2022.167334] [Reference Citation Analysis]
30 Manolova Sergieva K. Dosimetry Audit in Modern Radiotherapy. Radiation Oncology 2022. [DOI: 10.5772/intechopen.100941] [Reference Citation Analysis]
31 Lindner D, Arndt C, Loureiro LR, Feldmann A, Kegler A, Koristka S, Berndt N, Mitwasi N, Bergmann R, Frenz M, Bachmann MP. Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells. IJMS 2022;23:7922. [DOI: 10.3390/ijms23147922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Guesdon-Vennerie A, Couvreur P, Ali F, Pouzoulet F, Roulin C, Martínez-Rovira I, Bernadat G, Legrand FX, Bourgaux C, Mazars CL, Marco S, Trépout S, Mura S, Mériaux S, Bort G. Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application. Nat Commun 2022;13:4102. [PMID: 35835744 DOI: 10.1038/s41467-022-30917-0] [Reference Citation Analysis]
33 Kong Y, Zhao X, Xu M, Pan J, Ma Y, Zou L, Peng Q, Zhang J, Su C, Xu Z, Zhou W, Peng Y, Yang J, Zhou C, Li Y, Guo Q, Chen G, Wu H, Xing P, Zhang L. PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study. Front Immunol 2022;13:952066. [DOI: 10.3389/fimmu.2022.952066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Choi EK. Genetic variations affecting response of radiotherapy. J Genet Med 2022;19:1-6. [DOI: 10.5734/jgm.2022.19.1.1] [Reference Citation Analysis]
35 Kumar S, Ben Chouikha I, Kerkeni B, García G, Limão-vieira P. Bound Electron Enhanced Radiosensitisation of Nimorazole upon Charge Transfer. Molecules 2022;27:4134. [DOI: 10.3390/molecules27134134] [Reference Citation Analysis]
36 Lochmann C, Luxford TFM, Makurat S, Pysanenko A, Kočišek J, Rak J, Denifl S. Low-Energy Electron Induced Reactions in Metronidazole at Different Solvation Conditions. Pharmaceuticals 2022;15:701. [DOI: 10.3390/ph15060701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Liao Y, Wang D, Zhu S, Zhou R, Rahbarizadeh F, Gu Z. Piezoelectric materials for synergistic piezo- and radio-catalytic tumor therapy. Nano Today 2022;44:101510. [DOI: 10.1016/j.nantod.2022.101510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Srinivasan S, Dasgupta A, Chatterjee A, Baheti A, Engineer R, Gupta T, Murthy V. The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI Malignancies. JCO Glob Oncol 2022;8:e2100366. [PMID: 35609219 DOI: 10.1200/GO.21.00366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Darwis NDM, Horigome E, Li S, Adachi A, Oike T, Shibata A, Hirota Y, Ohno T. Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455. Cells 2022;11:1727. [PMID: 35681425 DOI: 10.3390/cells11111727] [Reference Citation Analysis]
40 Desai P, Rimal R, Sahnoun SEM, Mottaghy FM, Möller M, Morgenroth A, Singh S. Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers. Small. [DOI: 10.1002/smll.202200673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 ten Eikelder SCM, Ajdari A, Bortfeld T, den Hertog D. Adjustable robust treatment-length optimization in radiation therapy. Optim Eng. [DOI: 10.1007/s11081-021-09709-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Sun X, Yao F, Zhang H, Li J. Oxygen-generating materials and their biomedical applications: a review. J Mater Sci. [DOI: 10.1007/s10853-022-07229-1] [Reference Citation Analysis]
43 Yan D, Zhao Q, Du Z, Li H, Geng R, Yang W, Zhang X, Cao J, Yi N, Zhou J, Tang Z. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10601-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yadav P, Kundu P, Pandey VK, Amin PJ, Nair J, Shankar BS. Effects of prolonged treatment of TGF-βR inhibitor SB431542 on radiation-induced signaling in breast cancer cells. Int J Radiat Biol 2022;:1-18. [PMID: 35446183 DOI: 10.1080/09553002.2022.2069299] [Reference Citation Analysis]
45 Keall PJ, Brighi C, Glide-Hurst C, Liney G, Liu PZY, Lydiard S, Paganelli C, Pham T, Shan S, Tree AC, van der Heide UA, Waddington DEJ, Whelan B. Integrated MRI-guided radiotherapy - opportunities and challenges. Nat Rev Clin Oncol 2022. [PMID: 35440773 DOI: 10.1038/s41571-022-00631-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
46 Cai S, Yang Y, Kong Y, Guo Q, Xu Y, Xing P, Sun Y, Qian J, Xu R, Xie L, Hu Y, Wang M, Li M, Tian Y, Mao W. Gut Bacteria Erysipelatoclostridium and Its Related Metabolite Ptilosteroid A Could Predict Radiation-Induced Intestinal Injury. Front Public Health 2022;10:862598. [PMID: 35419331 DOI: 10.3389/fpubh.2022.862598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Mulder SL, Heukelom J, Mcdonald BA, Van Dijk L, Wahid KA, Sanders K, Salzillo TC, Hemmati M, Schaefer A, Fuller CD. MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers. Cancers 2022;14:1909. [DOI: 10.3390/cancers14081909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Jensen KH, Vogelius IR, Bernsdorf M, Gothelf A, Kristensen CA, Maare C, Andersen E, Specht L, Friborg J. Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma. Radiother Oncol 2022:S0167-8140(22)00169-4. [PMID: 35395275 DOI: 10.1016/j.radonc.2022.03.020] [Reference Citation Analysis]
49 Patil S, Linge A, Grosser M, Lohaus F, Gudziol V, Kemper M, Nowak A, Haim D, Tinhofer I, Budach V, Guberina M, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu A, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Boeke S, Zips D, Baretton GB, Baumann M, Krause M, Löck S. Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Sceni G, Sayyad SA, Tuscano C. Letter to the editor of radiotherapy and oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by berger et al. (December 2021, Volume 165). Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Wang P, Long F, Lin H, Wang S, Wang T. Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer. Oxid Med Cell Longev 2022;2022:7848811. [PMID: 35368867 DOI: 10.1155/2022/7848811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Galain I, Cardoso M, Tejería E, Mourglia-ettlin G, Arbildi P, Terán M, Pérez Barthaburu M, Aguiar I. Enhancement of radiation response of breast cancer cells through the incorporation of Bi2S3 nanorods. J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05455-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Jiang Y, Zhao W, Zhou H, Zhang Q, Zhang S. ATP-Triggered Intracellular In Situ Aggregation of a Gold-Nanoparticle-Equipped Triple-Helix Molecular Switch for Fluorescence Imaging and Photothermal Tumor Therapy. Langmuir 2022. [PMID: 35291761 DOI: 10.1021/acs.langmuir.1c03331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shchukin PV, Muftakhov MV, Khatymov RV, Tuktarov RF. Resonant electron capture by 5-Br-2′-deoxyuridine. J Chem Phys 2022;156:104304. [DOI: 10.1063/5.0077009] [Reference Citation Analysis]
55 Kroll F, Brack F, Bernert C, Bock S, Bodenstein E, Brüchner K, Cowan TE, Gaus L, Gebhardt R, Helbig U, Karsch L, Kluge T, Kraft S, Krause M, Lessmann E, Masood U, Meister S, Metzkes-ng J, Nossula A, Pawelke J, Pietzsch J, Püschel T, Reimold M, Rehwald M, Richter C, Schlenvoigt H, Schramm U, Umlandt MEP, Ziegler T, Zeil K, Beyreuther E. Tumour irradiation in mice with a laser-accelerated proton beam. Nat Phys 2022;18:316-22. [DOI: 10.1038/s41567-022-01520-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
56 Huart C, Fransolet M, Demazy C, Le Calvé B, Lucas S, Michiels C, Wéra A. Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263. Cancers 2022;14:1460. [DOI: 10.3390/cancers14061460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Viegas C, Pereira DSM, Fonte P. Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment. Materials 2022;15:2086. [DOI: 10.3390/ma15062086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kamal N, Ilowefah MA, Hilles AR, Anua NA, Awin T, Alshwyeh HA, Aldosary SK, Jambocus NGS, Alosaimi AA, Rahman A, Mahmood S, Mediani A. Genesis and Mechanism of Some Cancer Types and an Overview on the Role of Diet and Nutrition in Cancer Prevention. Molecules 2022;27:1794. [PMID: 35335158 DOI: 10.3390/molecules27061794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
59 Buchsbaum JC, Espey MG, Obcemea C, Capala J, Ahmed M, Prasanna PG, Vikram B, Hong JA, Teicher B, Aryankalayil MJ, Bylicky MA, Coleman CN. Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio. J Clin Oncol 2022;:JCO2102579. [PMID: 35245101 DOI: 10.1200/JCO.21.02579] [Reference Citation Analysis]
60 Eke I, Aryankalayil MJ, Bylicky MA, Makinde AY, Liotta L, Calvert V, Petricoin EF, Graves EE, Coleman CN. Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. Sci Rep 2022;12:3500. [PMID: 35241721 DOI: 10.1038/s41598-022-07394-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Huang X, Zha F, Zou J, Li Y, Wang F, Chen X. Photoacoustic Imaging‐Guided Synergistic Photothermal/Radiotherapy Using Plasmonic Bi/Bi 2 O 3−x Nanoparticles. Adv Funct Materials 2022;32:2113353. [DOI: 10.1002/adfm.202113353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
62 Gerlach S, Schlaefer A. Robotic Systems in Radiotherapy and Radiosurgery. Curr Robot Rep 2022;3:9-19. [DOI: 10.1007/s43154-021-00072-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Löck S, Linge A, Lohaus F, Ebert N, Gudziol V, Nowak A, Tinhofer I, Kalinauskaite G, Guberina M, Stuschke M, Balermpas P, von der Grün J, Grosu AL, Debus J, Ganswindt U, Belka C, Peeken JC, Combs SE, De-Colle C, Zips D, Baretton GB, Krause M, Baumann M; DKTK-ROG. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. Radiother Oncol 2022:S0167-8140(22)00094-9. [PMID: 35182686 DOI: 10.1016/j.radonc.2022.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
64 Li Y, Li X, Yang J, Wang S, Tang M, Xia J, Gao Y. Flourish of Proton and Carbon Ion Radiotherapy in China. Front Oncol 2022;12:819905. [DOI: 10.3389/fonc.2022.819905] [Reference Citation Analysis]
65 Fukunaga H, Yokoya A, Prise KM. A Brief Overview of Radiation-Induced Effects on Spermatogenesis and Oncofertility. Cancers (Basel) 2022;14:805. [PMID: 35159072 DOI: 10.3390/cancers14030805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Høyer M, Grau C, Overgaard J. No time to die - BiGART is back. The 20th Acta Oncologica Symposium - BIGART 2021. Acta Oncol 2022;61:117-9. [PMID: 34991422 DOI: 10.1080/0284186X.2021.2022206] [Reference Citation Analysis]
67 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Overgaard J, Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Offersen BV, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V, Baumann M. Personalised radiation therapy taking both the tumour and patient into consideration. Radiother Oncol 2022:S0167-8140(22)00014-7. [PMID: 35051440 DOI: 10.1016/j.radonc.2022.01.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Pan P, Dong X, Chen Y, Zeng X, Zhang XZ. Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma. ACS Nano 2022. [PMID: 35029367 DOI: 10.1021/acsnano.1c08350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
70 Michon S, Rodier F, Yu FTH. Targeted Anti-Cancer Provascular Therapy Using Ultrasound, Microbubbles, and Nitrite to Increase Radiotherapy Efficacy. Bioconjug Chem 2022. [PMID: 34990112 DOI: 10.1021/acs.bioconjchem.1c00510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gomes ER, Franco MS. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy. Pharmaceutics 2022;14:105. [PMID: 35057001 DOI: 10.3390/pharmaceutics14010105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Peters N, Muren LP. Towards an integral clinical proton dose prediction uncertainty by considering delineation variation. Physics and Imaging in Radiation Oncology 2022;21:134-5. [DOI: 10.1016/j.phro.2022.03.001] [Reference Citation Analysis]
73 Tiwari B, Chaudhary RK, Srivastava A, Kumar R, Sonawane M. Tissue-equivalent dosimeters based on copper doped lithium tetraborate single crystals for radiotherapy. Radiation Measurements 2022. [DOI: 10.1016/j.radmeas.2022.106704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Richter C, Wohlfahrt P. Dual-Energy CT in Radiation Oncology. Spectral Imaging 2022. [DOI: 10.1007/978-3-030-96285-2_23] [Reference Citation Analysis]
75 刘 根. The Relationship between Radiation Therapy and Immunotherapy. ACM 2022;12:1014-1021. [DOI: 10.12677/acm.2022.122148] [Reference Citation Analysis]
76 Lorenzo G, Hormuth Ii DA, Jarrett AM, Lima EABF, Subramanian S, Biros G, Oden JT, Hughes TJR, Yankeelov TE. Quantitative In Vivo Imaging to Enable Tumour Forecasting and Treatment Optimization. Emergence, Complexity and Computation 2022. [DOI: 10.1007/978-3-031-04379-6_3] [Reference Citation Analysis]
77 Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, Mancusi R, Ross JB, Takahashi N, Thomas A, Diehn M, Weissman IL, Graves EE, Sage J. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer 2022;3:1351-66. [PMID: 36411318 DOI: 10.1038/s43018-022-00456-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Huot JR, Pin F, Bonetto A. Therapy-Induced Toxicities Associated with the Onset of Cachexia. The Systemic Effects of Advanced Cancer 2022. [DOI: 10.1007/978-3-031-09518-4_8] [Reference Citation Analysis]
79 Yan Z, Zhang X, Liu Y, Shen Y, Li N, Jia Q, Ji Y, Zhang P, Zhao L, Meng Z. HSA-MnO2-131I Combined Imaging and Treatment of Anaplastic Thyroid Carcinoma. Technol Cancer Res Treat 2022;21:15330338221106557. [PMID: 35702054 DOI: 10.1177/15330338221106557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Essa RZ, Chew MT, Bradley DA, Peh S, Teow S. The Effects of Low-Dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_60] [Reference Citation Analysis]
81 Shaikh S. Molecular Imaging and Radiobiology. Advances in Imaging 2022. [DOI: 10.1007/978-981-16-9535-3_22] [Reference Citation Analysis]
82 Zhang A, Fang J, Li X, Wang J, Chen M, Chen H, He G, Xie X. Cellular nanointerface of vertical nanostructure arrays and its applications. Nanoscale Adv . [DOI: 10.1039/d1na00775k] [Reference Citation Analysis]
83 Scarborough JA, Scott JG. Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology. Semin Radiat Oncol 2022;32:42-53. [PMID: 34861995 DOI: 10.1016/j.semradonc.2021.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Dutz A, Zwanenburg A, Langendijk JA, Löck S. Modelling for Radiation Treatment Outcome. Image-Guided High-Precision Radiotherapy 2022. [DOI: 10.1007/978-3-031-08601-4_13] [Reference Citation Analysis]
85 Wieser HP, Huang Y, Schauer J, Lascaud J, Würl M, Lehrack S, Radonic D, Vidal M, Hérault J, Chmyrov A, Ntziachristos V, Assmann W, Parodi K, Dollinger G. Experimental demonstration of accurate Bragg peak localization with ionoacoustic tandem phase detection (iTPD). Phys Med Biol 2021;66. [PMID: 34847532 DOI: 10.1088/1361-6560/ac3ead] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Mueller M, Poulsen P, Hansen R, Verbakel W, Berbeco R, Ferguson D, Mori S, Ren L, Roeske JC, Wang L, Zhang P, Keall P. The markerless lung target tracking AAPM Grand Challenge (MATCH) results. Med Phys 2021. [PMID: 34913495 DOI: 10.1002/mp.15418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Appelt AL, Elhaminia B, Gooya A, Gilbert A, Nix M. Deep Learning for Radiotherapy Outcome Prediction Using Dose Data - A Review. Clin Oncol (R Coll Radiol) 2021:S0936-6555(21)00462-3. [PMID: 34924256 DOI: 10.1016/j.clon.2021.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Macaeva E, Tabury K, Michaux A, Janssen A, Averbeck N, Moreels M, De Vos WH, Baatout S, Quintens R. High-LET Carbon and Iron Ions Elicit a Prolonged and Amplified p53 Signaling and Inflammatory Response Compared to low-LET X-Rays in Human Peripheral Blood Mononuclear Cells. Front Oncol 2021;11:768493. [PMID: 34888245 DOI: 10.3389/fonc.2021.768493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Monzen S, Ueno T, Chiba M, Morino Y, Mariya Y, Wojcik A, Lundholm L. Dose-dependent expression of extracellular microRNAs in HCT116 colorectal cancer cells exposed to high-dose-rate ionising radiation. Mol Clin Oncol 2022;16:19. [PMID: 34881039 DOI: 10.3892/mco.2021.2452] [Reference Citation Analysis]
90 Zhang J, Zhu Y, Zhang Y, Lin W, Ke J, Liu J, Zhang L, Liu J. A balanced charged hydrogel with anti-biofouling and antioxidant properties for treatment of irradiation-induced skin injury. Mater Sci Eng C Mater Biol Appl 2021;131:112538. [PMID: 34857314 DOI: 10.1016/j.msec.2021.112538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Jahnke T, Guillemin R, Inhester L, Son S, Kastirke G, Ilchen M, Rist J, Trabert D, Melzer N, Anders N, Mazza T, Boll R, De Fanis A, Music V, Weber T, Weller M, Eckart S, Fehre K, Grundmann S, Hartung A, Hofmann M, Janke C, Kircher M, Nalin G, Pier A, Siebert J, Strenger N, Vela-perez I, Baumann T, Grychtol P, Montano J, Ovcharenko Y, Rennhack N, Rivas D, Wagner R, Ziolkowski P, Schmidt P, Marchenko T, Travnikova O, Journel L, Ismail I, Kukk E, Niskanen J, Trinter F, Vozzi C, Devetta M, Stagira S, Gisselbrecht M, Jäger A, Li X, Malakar Y, Martins M, Feifel R, Schmidt L, Czasch A, Sansone G, Rolles D, Rudenko A, Moshammer R, Dörner R, Meyer M, Pfeifer T, Schöffler M, Santra R, Simon M, Piancastelli M. Inner-Shell-Ionization-Induced Femtosecond Structural Dynamics of Water Molecules Imaged at an X-Ray Free-Electron Laser. Phys Rev X 2021;11. [DOI: 10.1103/physrevx.11.041044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Van den Broek B, Wuyts C, Irobi J. Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond. Adv Drug Deliv Rev 2021;179:114009. [PMID: 34673130 DOI: 10.1016/j.addr.2021.114009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Dietrich A, Scheffler B, Eggert A, Peters C, Serve H, Schuler M, Schulze-osthoff K, Weichert W, Wick W, Weyrich U, Baumann M, Krause M. Das Deutsche Konsortium für Translationale Krebsforschung. Forum 2021;36:465-473. [DOI: 10.1007/s12312-021-01014-y] [Reference Citation Analysis]
94 Wegge M, Dok R, Nuyts S. Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer. Cancers (Basel) 2021;13:5959. [PMID: 34885069 DOI: 10.3390/cancers13235959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
95 Kranthikumar R. Toward the synthesis of the hypoxia selective anticancer agent BE-43547 A2. Org Biomol Chem 2021;19:9833-9. [PMID: 34734961 DOI: 10.1039/d1ob01824h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ten Eikelder SCM, Ajdari A, Bortfeld T, den Hertog D. Conic formulation of fluence map optimization problems. Phys Med Biol 2021;66. [PMID: 34587600 DOI: 10.1088/1361-6560/ac2b82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Suwanraksa C, Liamsuwan T, Chaichulee S. Deep learning techniques for synthetic CT generation: a single model for multiple anatomical sites. 2021 13th Biomedical Engineering International Conference (BMEiCON) 2021. [DOI: 10.1109/bmeicon53485.2021.9745200] [Reference Citation Analysis]
98 de Mey S, Dufait I, De Ridder M. Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures. Front Oncol 2021;11:761901. [PMID: 34778082 DOI: 10.3389/fonc.2021.761901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Alkiş ME, Yeşilbaş S. Effect of electroporation on radiotherapy treatment in human hepatocellular carcinoma cells. Journal of Physical Chemistry and Functional Materials 2021. [DOI: 10.54565/jphcfum.1006281] [Reference Citation Analysis]
100 Gao F, Yang Y, Zhu H, Wang J, Xiao D, Zhou Z, Dai T, Zhang Y, Feng G, Li J, Lin B, Xie G, Ke Q, Zhou K, Li P, Shen X, Wang H, Yan L, Lao C, Shan L, Li M, Lu Y, Chen M, Feng S, Zhao J, Wu D, Du X. First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays. Radiother Oncol 2021;166:44-50. [PMID: 34774651 DOI: 10.1016/j.radonc.2021.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
101 Peters N, Wohlfahrt P, Hofmann C, Möhler C, Menkel S, Tschiche M, Krause M, Troost EGC, Enghardt W, Richter C. Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction. Radiother Oncol 2021;166:71-8. [PMID: 34774653 DOI: 10.1016/j.radonc.2021.11.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
102 Frosina G, Fontana V, Verzola D, Rosa A, Gaggero G, Garibotto G, Vagge S, Pigozzi S, Daga A. Ultra-hyper-fractionated radiotherapy for high-grade gliomas. J Neurosci Res 2021. [PMID: 34747065 DOI: 10.1002/jnr.24929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Elbanna M, Chowdhury NN, Rhome R, Fishel ML. Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy. Front Oncol 2021;11:749496. [PMID: 34733787 DOI: 10.3389/fonc.2021.749496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg 2021;8:34. [PMID: 34727233 DOI: 10.1186/s40580-021-00282-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
105 Zhang J, Yang L, Huang F, Zhao C, Liu J, Zhang Y, Liu J. Multifunctional Hybrid Hydrogel Enhanced Antitumor Therapy through Multiple Destroying DNA Functions by a Triple-Combination Synergistic Therapy. Adv Healthc Mater 2021;10:e2101190. [PMID: 34382378 DOI: 10.1002/adhm.202101190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
106 Longarino FK, Tessonnier T, Mein S, Harrabi SB, Debus J, Stiller W, Mairani A. Dual-layer spectral CT for proton, helium, and carbon ion beam therapy planning of brain tumors. J Appl Clin Med Phys 2021. [PMID: 34724327 DOI: 10.1002/acm2.13465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Zheng L, Zhu R, Chen L, Fu Q, Li J, Chen C, Song J, Yang H. X-ray sensitive high-Z metal nanocrystals for cancer imaging and therapy. Nano Res 2021;14:3744-55. [DOI: 10.1007/s12274-021-3337-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
108 Hafizovic L, Causevic A, Deumic A, Becirovic LS, Pokvic LG, Badnjevic A. The Use of Artificial Intelligence in Diagnostic Medical Imaging: Systematic Literature Review. 2021 IEEE 21st International Conference on Bioinformatics and Bioengineering (BIBE) 2021. [DOI: 10.1109/bibe52308.2021.9635307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Yu J, Zhang J, Jin J, Jiang W. Microenvironment-responsive DNA-conjugated albumin nanocarriers for targeted therapy. J Mater Chem B 2021;9:8424-36. [PMID: 34542145 DOI: 10.1039/d1tb01022k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
110 Blomain ES, Moding EJ. Liquid Biopsies for Molecular Biology-Based Radiotherapy. Int J Mol Sci 2021;22:11267. [PMID: 34681925 DOI: 10.3390/ijms222011267] [Reference Citation Analysis]
111 Zandi A, Rafizadeh-Tafti S, Shojaeian F, Ali Khayamian M, Abbasvandi F, Faranoush M, Anbiaee R, Najafikhoshnoo S, Hoseinpour P, Assadi S, Katebi P, Davari Sh Z, Shalileh S, Salemizadeh Parizi M, Vanaei S, Ghaderinia M, Abadijoo H, Taheri P, Reza Esmailinejad M, Sanati H, Reza Rostami M, Sadeghian R, Kordehlachin Y, Sadegh Mousavi-Kiasary SM, Mamdouh A, Hossein Miraghaie S, Baharvand H, Abdolahad M. Positive electrostatic therapy of metastatic tumors: selective induction of apoptosis in cancer cells by pure charges. Cancer Med 2021;10:7475-91. [PMID: 34626092 DOI: 10.1002/cam4.4267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Esposito F, Giuffrida R, Raciti G, Puglisi C, Forte S. Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy. Int J Mol Sci 2021;22:10689. [PMID: 34639030 DOI: 10.3390/ijms221910689] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
113 Ghate A. Response-Guided Dosing in Cancer Radiotherapy. Tutorials in Operations Research: Emerging Optimization Methods and Modeling Techniques with Applications 2021. [DOI: 10.1287/educ.2021.0227] [Reference Citation Analysis]
114 Nathansen J, Meyer F, Müller L, Schmitz M, Borgmann K, Dubrovska A. Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation. Cancers (Basel) 2021;13:4818. [PMID: 34638302 DOI: 10.3390/cancers13194818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
115 Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A, Ronchi S, Fiore MR, Paganelli C, Buizza G, Ciocca M, Baroni G, Preda L, Orlandi E. Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review. Br J Radiol 2021;94:20210524. [PMID: 34520670 DOI: 10.1259/bjr.20210524] [Reference Citation Analysis]
116 Ray X, Sumner W, Sutton L, Sanghvi P, Deichaite I, Moiseenko V. Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy. J Transl Med 2021;19:380. [PMID: 34493300 DOI: 10.1186/s12967-021-03047-2] [Reference Citation Analysis]
117 Zientara N, Giles E, Le H, Short M. A scoping review of patient selection methods for proton therapy. J Med Radiat Sci 2021. [PMID: 34476905 DOI: 10.1002/jmrs.540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
118 Sørensen BS, Pawelke J, Bauer J, Burnet NG, Dasu A, Høyer M, Karger CP, Krause M, Schwarz M, Underwood TSA, Wagenaar D, Whitfield GA, Lühr A. Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? Radiother Oncol 2021;163:177-84. [PMID: 34480959 DOI: 10.1016/j.radonc.2021.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
119 Ankjærgaard C, Johansen A, von Staffeldt M, Andersen C, Madsen D, Behrens C. Irradiation of subcutaneous mouse tumors with a clinical linear accelerator validated by alanine dosimetry. Radiation Measurements 2021;147:106636. [DOI: 10.1016/j.radmeas.2021.106636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
120 Lin SH, Willers H, Krishnan S, Sarkaria JN, Baumann M, Lawrence TS. Moving Beyond the Standard of Care: Accelerate Testing of Radiation-Drug Combinations. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02706-1. [PMID: 34454045 DOI: 10.1016/j.ijrobp.2021.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
121 Suckert T, Nexhipi S, Dietrich A, Koch R, Kunz-Schughart LA, Bahn E, Beyreuther E. Models for Translational Proton Radiobiology-From Bench to Bedside and Back. Cancers (Basel) 2021;13:4216. [PMID: 34439370 DOI: 10.3390/cancers13164216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
122 Wang X, Pan H, Cheng Q, Wang X, Xu W. Dosimetric Deviations of Bragg-Peak Position Shifts in Uniform Magnetic Fields for Magnetic Resonance Imaging-Guiding Proton Radiotherapy: A Monte Carlo Study. Front Public Health 2021;9:641915. [PMID: 34414150 DOI: 10.3389/fpubh.2021.641915] [Reference Citation Analysis]
123 Manem VSK. Development and validation of genomic predictors of radiation sensitivity using preclinical data. BMC Cancer 2021;21:937. [PMID: 34416855 DOI: 10.1186/s12885-021-08652-4] [Reference Citation Analysis]
124 Jiang W, Li X, Dong S, Zhou W. Betulinic acid in the treatment of tumour diseases: Application and research progress. Biomed Pharmacother 2021;142:111990. [PMID: 34388528 DOI: 10.1016/j.biopha.2021.111990] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
125 Mi Z, Chen CB, Tan HQ, Dou Y, Yang C, Turaga SP, Ren M, Vajandar SK, Yuen GH, Osipowicz T, Watt F, Bettiol AA. Quantifying nanodiamonds biodistribution in whole cells with correlative iono-nanoscopy. Nat Commun 2021;12:4657. [PMID: 34341359 DOI: 10.1038/s41467-021-25004-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
126 Prasanna PG, Rawojc K, Guha C, Buchsbaum JC, Miszczyk JU, Coleman CN. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities. Int J Radiat Oncol Biol Phys 2021;110:1325-40. [PMID: 33640423 DOI: 10.1016/j.ijrobp.2021.02.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
127 Zhang W, Wang K, Zeng Y, Hu X, Zhang X, Chang S, Zhang H. Low-Diffusion Fricke Gel Dosimeters with Core-Shell Structure Based on Spatial Confinement. Materials (Basel) 2021;14:3932. [PMID: 34300851 DOI: 10.3390/ma14143932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Saager M, Hahn EW, Peschke P, Brons S, Huber PE, Debus J, Karger CP. Ramipril reduces incidence and prolongates latency time of radiation-induced rat myelopathy after photon and carbon ion irradiation. J Radiat Res 2020;61:791-8. [PMID: 32657322 DOI: 10.1093/jrr/rraa042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
129 Berthold J, Khamfongkhruea C, Petzoldt J, Thiele J, Hölscher T, Wohlfahrt P, Peters N, Jost A, Hofmann C, Janssens G, Smeets J, Richter C. First-In-Human Validation of CT-Based Proton Range Prediction Using Prompt Gamma Imaging in Prostate Cancer Treatments. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)00843-9. [PMID: 34229052 DOI: 10.1016/j.ijrobp.2021.06.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
130 Placidi L, Castriconi R, Rancati T, Lecchi M, Fusi F, Russo P, Cavedon C, Fiorino C, Garibaldi C. The scientific publications of AIFM members in 2015-2019: A survey of the FutuRuS working group. Phys Med 2021;88:111-6. [PMID: 34225239 DOI: 10.1016/j.ejmp.2021.06.011] [Reference Citation Analysis]
131 Tinganelli W, Luoni F, Durante M. What can space radiation protection learn from radiation oncology? Life Sci Space Res (Amst) 2021;30:82-95. [PMID: 34281668 DOI: 10.1016/j.lssr.2021.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Ebert MA, Gulliford S, Acosta O, de Crevoisier R, McNutt T, Heemsbergen WD, Witte M, Palma G, Rancati T, Fiorino C. Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations. Phys Med Biol 2021;66. [PMID: 34049304 DOI: 10.1088/1361-6560/ac0681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
133 Verger E, Cheng J, de Santis V, Iafrate M, Jackson JA, Imberti C, Fruhwirth GO, Blower PJ, Ma MT, Burnham DR, Terry SYA. Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy. Nucl Med Biol 2021;100-101:36-43. [PMID: 34153932 DOI: 10.1016/j.nucmedbio.2021.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Matschke J, Larafa S, Jendrossek V. Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer? Biochem Soc Trans 2021;49:1265-77. [PMID: 34110407 DOI: 10.1042/BST20200866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Stein JN, Rivera MP, Weiner A, Duma N, Henderson L, Mody G, Charlot M. Sociodemographic disparities in the management of advanced lung cancer: a narrative review. J Thorac Dis 2021;13:3772-800. [PMID: 34277069 DOI: 10.21037/jtd-20-3450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Simovic M, Bolkestein M, Moustafa M, Wong JKL, Körber V, Benedetto S, Khalid U, Schreiber HS, Jugold M, Korshunov A, Hübschmann D, Mack N, Brons S, Wei PC, Breckwoldt MO, Heiland S, Bendszus M, Jürgen D, Höfer T, Zapatka M, Kool M, Pfister SM, Abdollahi A, Ernst A. Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model. Neuro Oncol 2021:noab127. [PMID: 34049392 DOI: 10.1093/neuonc/noab127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
137 Bian Z, Shi L, Kidder K, Zen K, Garnett-Benson C, Liu Y. Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy. Nat Commun 2021;12:3229. [PMID: 34050181 DOI: 10.1038/s41467-021-23442-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
138 Lin B, Gao F, Yang Y, Wu D, Zhang Y, Feng G, Dai T, Du X. FLASH Radiotherapy: History and Future. Front Oncol 2021;11:644400. [PMID: 34113566 DOI: 10.3389/fonc.2021.644400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
139 Harish K. Desk of the editor (Addendum Vol.12 Issue 1 E). Indian J Surg Oncol 2021;12:238. [PMID: 34295063 DOI: 10.1007/s13193-021-01355-z] [Reference Citation Analysis]
140 Yu Z, Gao L, Chen K, Zhang W, Zhang Q, Li Q, Hu K. Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment. Nanoscale Res Lett 2021;16:88. [PMID: 34014432 DOI: 10.1186/s11671-021-03489-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
141 Sumner W, Ray X, Sutton L, Rebibo D, Marincola F, Sanghvi P, Moiseenko V, Deichaite I. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma. J Transl Med 2021;19:212. [PMID: 34001187 DOI: 10.1186/s12967-021-02876-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
142 Shakya Y, Inhester L, Arnold C, Welsch R, Santra R. Ultrafast time-resolved x-ray absorption spectroscopy of ionized urea and its dimer through ab initio nonadiabatic dynamics. Structural Dynamics 2021;8:034102. [DOI: 10.1063/4.0000076] [Reference Citation Analysis]
143 Pritchard JL, Velthuis JJ, Beck L, De Sio C, Hugtenburg RP. High-Resolution MLC Leaf Position Measurements With a Large Area MAPS. IEEE Trans Radiat Plasma Med Sci 2021;5:392-7. [DOI: 10.1109/trpms.2020.3007859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Dutz A, Lühr A, Troost EGC, Agolli L, Bütof R, Valentini C, Baumann M, Vermeren X, Geismar D, Timmermann B, Krause M, Löck S. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses. Radiother Oncol 2021;160:69-77. [PMID: 33872640 DOI: 10.1016/j.radonc.2021.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
145 Perillo A, Agbaje Olufemi MV, De Robbio J, Mancuso RM, Roscigno A, Tirozzi M, Scognamiglio IR. Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00038] [Reference Citation Analysis]
146 Peng S, Song R, Lin Q, Zhang Y, Yang Y, Luo M, Zhong Z, Xu X, Lu L, Yao S, Zhang F. A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy. Adv Sci (Weinh) 2021;8:2002567. [PMID: 33854878 DOI: 10.1002/advs.202002567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
147 Dutz A, Lühr A, Agolli L, Bütof R, Valentini C, Troost EG, Baumann M, Vermeren X, Geismar D, Lamba N, Lebow ES, Bussière M, Daly JE, Bussière MR, Krause M, Timmermann B, Shih HA, Löck S. Modelling of late side-effects following cranial proton beam therapy. Radiotherapy and Oncology 2021;157:15-23. [DOI: 10.1016/j.radonc.2021.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
148 Zeng L, Cao Y, He L, Ding S, Bian XW, Tian G. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy. J Mater Chem B 2021;9:208-27. [PMID: 33215626 DOI: 10.1039/d0tb02294b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
149 Qi Y, Li J, Chen H, Guo Y, Yin Y, Gong G, Wang L. Computer-aided diagnosis and regional segmentation of nasopharyngeal carcinoma based on multi-modality medical images. Int J Comput Assist Radiol Surg 2021;16:871-82. [PMID: 33782844 DOI: 10.1007/s11548-021-02351-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ajdari A, Xie Y, Richter C, Niyazi M, Duda DG, Hong TS, Bortfeld T. Toward Personalized Radiation Therapy of Liver Metastasis: Importance of Serial Blood Biomarkers. JCO Clin Cancer Inform 2021;5:315-25. [PMID: 33764817 DOI: 10.1200/CCI.20.00118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Lombardo E, Kurz C, Marschner S, Avanzo M, Gagliardi V, Fanetti G, Franchin G, Stancanello J, Corradini S, Niyazi M, Belka C, Parodi K, Riboldi M, Landry G. Distant metastasis time to event analysis with CNNs in independent head and neck cancer cohorts. Sci Rep 2021;11:6418. [PMID: 33742070 DOI: 10.1038/s41598-021-85671-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
152 Rühle A, Grosu AL, Wiedenmann N, Stoian R, Haehl E, Zamboglou C, Baltas D, Werner M, Kayser G, Nicolay NH. Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial. Radiother Oncol 2021;159:75-81. [PMID: 33753155 DOI: 10.1016/j.radonc.2021.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
153 Aristei C, Perrucci E, Alì E, Marazzi F, Masiello V, Saldi S, Ingrosso G. Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer. Front Oncol 2021;11:616042. [PMID: 33816246 DOI: 10.3389/fonc.2021.616042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
154 Tsai TL, Lai YH, Hw Chen H, Su WC. Overcoming Radiation Resistance by Iron-Platinum Metal Alloy Nanoparticles in Human Copper Transport 1-Overexpressing Cancer Cells via Mitochondrial Disturbance. Int J Nanomedicine 2021;16:2071-85. [PMID: 33727814 DOI: 10.2147/IJN.S283147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
155 Ciecior W, Ebert N, Borgeaud N, Thames HD, Baumann M, Krause M, Löck S. Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour models. Radiother Oncol 2021;158:262-7. [PMID: 33667590 DOI: 10.1016/j.radonc.2021.02.032] [Reference Citation Analysis]
156 Choi C, Lee GH, Son A, Yoo GS, Yu JI, Park HC. Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells. Cells 2021;10:554. [PMID: 33806487 DOI: 10.3390/cells10030554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
157 Meißner R, Feketeová L, Bayer A, Limão-Vieira P, Denifl S. Formation of negative and positive ions in the radiosensitizer nimorazole upon low-energy electron collisions. J Chem Phys 2021;154:074306. [PMID: 33607883 DOI: 10.1063/5.0040045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
158 Zheng Z, Zhou Z, Zhang Q, Zhou X, Yang J, Yang MR, Zhu GY, Jiang ZH, Li T, Lin Q, Bai LP. Non-classical cardenolides from Calotropis gigantea exhibit anticancer effect as HIF-1 inhibitors. Bioorg Chem 2021;109:104740. [PMID: 33626453 DOI: 10.1016/j.bioorg.2021.104740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
159 Riechelmann H, Steinbichler TB, Sprung S, Santer M, Runge A, Ganswindt U, Gamerith G, Dudas J. The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer. Cancers (Basel) 2021;13:772. [PMID: 33673269 DOI: 10.3390/cancers13040772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
160 Díaz-Gavela AA, Del Cerro Peñalver E, Sanchez García S, Leonardo Guerrero L, Sanz Rosa D, Couñago Lorenzo F. Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine. Breast Dis 2021;40:1-16. [PMID: 33554881 DOI: 10.3233/BD-201022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch H, Steinbach J, Kotzerke J, Baumann M, Krause M. Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial. Radiotherapy and Oncology 2021;155:285-92. [DOI: 10.1016/j.radonc.2020.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
162 Sang W, Xie L, Wang G, Li J, Zhang Z, Li B, Guo S, Deng CX, Dai Y. Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy. Adv Sci (Weinh) 2021;8:2003338. [PMID: 33643804 DOI: 10.1002/advs.202003338] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
163 van Houdt PJ, Yang Y, van der Heide UA. Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy. Front Oncol 2020;10:615643. [PMID: 33585242 DOI: 10.3389/fonc.2020.615643] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
164 Amaldi U, Benedetto E, Damjanovic S, Dosanjh M, Durante M, Georgieva P, Haberer T, Plesko M, Ristova M, Rossi S, Sammut N, Sapinski M, Schopper H, Specht H, Voss R, Vretenar M, Wenninger H. South East European International Institute for Sustainable Technologies (SEEIIST). Front Phys 2021;8. [DOI: 10.3389/fphy.2020.567466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
165 Yang KL, Chi MS, Ko HL, Huang YY, Huang SC, Lin YM, Chi KH. Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial. Radiat Oncol 2021;16:18. [PMID: 33472666 DOI: 10.1186/s13014-020-01742-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
166 Bortfeld T, Shusharina N, Craft D. Probabilistic definition of the clinical target volume-implications for tumor control probability modeling and optimization. Phys Med Biol 2021;66:01NT01. [PMID: 33197905 DOI: 10.1088/1361-6560/abcad8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
167 Hotta M, Minamimoto R, Toyohara J, Nohara K, Nakajima K, Takase K, Yamada K. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT. Eur J Nucl Med Mol Imaging 2021;48:2615-23. [PMID: 33438100 DOI: 10.1007/s00259-020-05179-x] [Reference Citation Analysis]
168 Alkhatib H, Rubinstein AM, Vasudevan S, Flashner-abramson E, Stefansky S, Oguche S, Peretz-yablonsky T, Granit A, Granot Z, Ben-porath I, Sheva K, Meirovitz A, Kravchenko-balasha N. Mapping cellular subpopulations within triple negative breast cancer tumors provides a tool for cancer sensitization to radiotherapy.. [DOI: 10.1101/2021.01.07.425553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
169 Belgioia L, Morbelli SD, Corvò R. Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research. Front Oncol 2020;10:604965. [PMID: 33489911 DOI: 10.3389/fonc.2020.604965] [Reference Citation Analysis]
170 Fiorino C, Jeraj R, Clark CH, Garibaldi C, Georg D, Muren L, van Elmpt W, Bortfeld T, Jornet N. In reply to the letter to the editor: "In reply to Fiorino et al: The central role of the radiation oncologist in the multidisciplinary and multiprofessional model of modern radiation therapy". Radiother Oncol 2021;155:e22-3. [PMID: 33412208 DOI: 10.1016/j.radonc.2020.12.033] [Reference Citation Analysis]
171 Mackenzie P, Vajdic C, Delaney G, Gabriel G, Agar M, Comans T, Barton M. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia. Tech Innov Patient Support Radiat Oncol 2020;16:17-23. [PMID: 33385070 DOI: 10.1016/j.tipsro.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
172 Dosch H, Adam G, Grosu A, Purschke M. Introduction. Classic Texts in the Sciences 2021. [DOI: 10.1007/978-3-030-72243-2_2] [Reference Citation Analysis]
173 Shakfa N, Siemens DR, Koti M. Revisiting immunogenic cell death to improve treatment response in cancer. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance 2021. [DOI: 10.1016/b978-0-12-821310-0.00008-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Niu L, Jang E, Chin AL, Tong R. External stimuli-responsive nanomedicine for cancer immunotherapy. Reference Module in Materials Science and Materials Engineering 2021. [DOI: 10.1016/b978-0-12-822425-0.00026-9] [Reference Citation Analysis]
175 Jiang M, Yang J, Li K, Liu J, Jing X, Tang M. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer. Int J Med Sci 2021;18:626-38. [PMID: 33437197 DOI: 10.7150/ijms.49544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
176 Kang M, Hasan S, Press RH, Yu F, Abdo M, Xiong W, Choi JI, Simone CB 2nd, Lin H. Using patient-specific bolus for pencil beam scanning proton treatment of periorbital disease. J Appl Clin Med Phys 2021;22:203-9. [PMID: 33369041 DOI: 10.1002/acm2.13134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
177 Otazo R, Lambin P, Pignol JP, Ladd ME, Schlemmer HP, Baumann M, Hricak H. MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology. Radiology 2021;298:248-60. [PMID: 33350894 DOI: 10.1148/radiol.2020202747] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
178 Ten Eikelder SCM, Ferjančič P, Ajdari A, Bortfeld T, den Hertog D, Jeraj R. Optimal treatment plan adaptation using mid-treatment imaging biomarkers. Phys Med Biol 2020;65:245011. [PMID: 33053518 DOI: 10.1088/1361-6560/abc130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
179 Vinnikov V, Hande MP, Wilkins R, Wojcik A, Zubizarreta E, Belyakov O. Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients Using Ex Vivo Induced Biodosimetric Markers: A Review. J Pers Med 2020;10:E285. [PMID: 33339312 DOI: 10.3390/jpm10040285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
180 Li Y, Li P, Hsi W, Hong Z, Fu S, Zhang Q. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer. Radiother Oncol 2021;156:69-79. [PMID: 33309999 DOI: 10.1016/j.radonc.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
181 Zschaeck S, Zöphel K, Seidlitz A, Zips D, Kotzerke J, Baumann M, Troost EGC, Löck S, Krause M. Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer. Radiother Oncol 2021;155:204-11. [PMID: 33252044 DOI: 10.1016/j.radonc.2020.10.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 Fiorino C, Jeraj R, Clark CH, Garibaldi C, Georg D, Muren L, van Elmpt W, Bortfeld T, Jornet N. Grand challenges for medical physics in radiation oncology. Radiotherapy and Oncology 2020;153:7-14. [DOI: 10.1016/j.radonc.2020.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
183 Schüller A, Heinrich S, Fouillade C, Subiel A, De Marzi L, Romano F, Peier P, Trachsel M, Fleta C, Kranzer R, Caresana M, Salvador S, Busold S, Schönfeld A, Mcewen M, Gomez F, Solc J, Bailat C, Linhart V, Jakubek J, Pawelke J, Borghesi M, Kapsch R, Knyziak A, Boso A, Olsovcova V, Kottler C, Poppinga D, Ambrozova I, Schmitzer C, Rossomme S, Vozenin M. The European Joint Research Project UHDpulse – Metrology for advanced radiotherapy using particle beams with ultra-high pulse dose rates. Physica Medica 2020;80:134-50. [DOI: 10.1016/j.ejmp.2020.09.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
184 Chew AH, Chandramouli N, Kanesvaran R, Iyer GN, Hwang WY. Winning the Fight Against Cancer. Ann Acad Med Singap 2020;49:779-788. [DOI: 10.47102/annals-acadmedsg.2020204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Gao F, Yang Y, Zhu H, Wang J, Xiao D, Zhou Z, Dai T, Zhang Y, Feng G, Li J, Lin B, Xie G, Ke Q, Zhou K, Li P, Shen X, Wang H, Yan L, Lao C, Shan L, Li M, Lu Y, Chen M, Feng S, Zhao J, Wu D, Du X. First demonstration of the FLASH effect with ultrahigh dose-rate high-energy X-rays.. [DOI: 10.1101/2020.11.27.401869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
186 Chen Y, Yang J, Fu S, Wu J. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine 2020;15:9407-30. [PMID: 33262595 DOI: 10.2147/IJN.S272902] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 15.7] [Reference Citation Analysis]
187 Rabasco Meneghetti A, Zwanenburg A, Löck S. Pictures worth more than a thousand words: Prediction of survival in medulloblastoma patients. EBioMedicine 2020;62:103136. [PMID: 33227586 DOI: 10.1016/j.ebiom.2020.103136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Gonnelli A, Montrone S, Cocuzza P, Ursino S, Manfredi B, Mattioni R, Coccia N, Fuentes T, Calistri E, Pasqualetti F, Paiar F. Radiotherapy in the COVID-19 Pandemic Era. In Vivo 2020;34:3731-4. [PMID: 33144491 DOI: 10.21873/invivo.12222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
189 Gray M, Meehan J, Turnbull AK, Martínez-Pérez C, Kay C, Pang LY, Argyle DJ. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology. Front Vet Sci 2020;7:598338. [PMID: 33282935 DOI: 10.3389/fvets.2020.598338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
190 Damasco JA, Ravi S, Perez JD, Hagaman DE, Melancon MP. Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine. Nanomaterials (Basel) 2020;10:E2186. [PMID: 33147800 DOI: 10.3390/nano10112186] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
191 Olcina MM, Stavros M, Nambiar DK, Kim RK, Casey KM, Rie VE, Woodruff TM, Graves EG, Quynh-thu L, Manuel S, Giaccia AJ. Targeting C5aR1 Increases the Therapeutic Window of Radiotherapy.. [DOI: 10.1101/2020.10.27.358036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Sertorio M, Nowrouzi A, Akbarpour M, Chetal K, Salomonis N, Brons S, Mascia A, Ionascu D, McCauley S, Kupneski T, Köthe A, Debus J, Perentesis JP, Abdollahi A, Zheng Y, Wells SI. Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma. Radiother Oncol 2021;155:293-303. [PMID: 33096164 DOI: 10.1016/j.radonc.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
193 Morozov VN, Belousov AV, Zverev VI, Shtil AA, Kolyvanova MA, Krivoshapkin PV. The Prospects of Metal Oxide Nanoradiosensitizers: The Effect of the Elemental Composition of Particles and Characteristics of Radiation Sources on Enhancement of the Adsorbed Dose. BIOPHYSICS 2020;65:533-40. [DOI: 10.1134/s0006350920040107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
194 Leger S, Zwanenburg A, Leger K, Lohaus F, Linge A, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Boeke S, Zips D, Richter C, Krause M, Baumann M, Troost EGC, Löck S. Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC. Cancers (Basel) 2020;12:E3047. [PMID: 33086761 DOI: 10.3390/cancers12103047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
195 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]
196 Marhold M, Topakian T, Agis H, Bartsch R, Berghoff AS, Brodowicz T, Fuereder T, Ilhan-Mutlu A, Kiesewetter B, Krainer M, Locker GJ, Marosi C, Prager G, Schmidinger M, Thallinger C, Zöchbauer-Müller S, Raderer M, Preusser M, Lamm W. Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field. ESMO Open 2020;5:e000880. [PMID: 33051192 DOI: 10.1136/esmoopen-2020-000880] [Reference Citation Analysis]
197 Kazmierska J, Hope A, Spezi E, Beddar S, Nailon WH, Osong B, Ankolekar A, Choudhury A, Dekker A, Redalen KR, Traverso A. From multisource data to clinical decision aids in radiation oncology: The need for a clinical data science community. Radiother Oncol 2020;153:43-54. [PMID: 33065188 DOI: 10.1016/j.radonc.2020.09.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
198 Desideri I, Loi M, Francolini G, Becherini C, Livi L, Bonomo P. Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art. Front Oncol 2020;10:1708. [PMID: 33117669 DOI: 10.3389/fonc.2020.01708] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
199 Hu K, Xie L, Hanyu M, Zhang Y, Li L, Ma X, Nagatsu K, Suzuki H, Wang W, Zhang MR. Harnessing the PD-L1 interface peptide for positron emission tomography imaging of the PD-1 immune checkpoint. RSC Chem Biol 2020;1:214-24. [PMID: 34458761 DOI: 10.1039/d0cb00070a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
200 Chen Y, Wang J, Li X, Hu N, Voelcker NH, Xie X, Elnathan R. Emerging Roles of 1D Vertical Nanostructures in Orchestrating Immune Cell Functions. Adv Mater 2020;32:e2001668. [PMID: 32844502 DOI: 10.1002/adma.202001668] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
201 Romano F, Subiel A, Mcmanus M, Lee ND, Palmans H, Thomas R, Mccallum S, Milluzzo G, Borghesi M, Mcilvenny A, Ahmed H, Farabolini W, Gilardi A, Schüller A. Challenges in dosimetry of particle beams with ultra-high pulse dose rates. J Phys : Conf Ser 2020;1662:012028. [DOI: 10.1088/1742-6596/1662/1/012028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
202 Defeudis A, De Mattia C, Rizzetto F, Calderoni F, Mazzetti S, Torresin A, Vanzulli A, Regge D, Giannini V. Standardization of CT radiomics features for multi-center analysis: impact of software settings and parameters. Phys Med Biol 2020;65:195012. [PMID: 32575082 DOI: 10.1088/1361-6560/ab9f61] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
203 Starke S, Leger S, Zwanenburg A, Leger K, Lohaus F, Linge A, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Boeke S, Zips D, Richter C, Troost EGC, Krause M, Baumann M, Löck S. 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma. Sci Rep 2020;10:15625. [PMID: 32973220 DOI: 10.1038/s41598-020-70542-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
204 Permatasari FF, Eulitz J, Richter C, Wohlfahrt P, Lühr A. Material assignment for proton range prediction in Monte Carlo patient simulations using stopping-power datasets. Phys Med Biol 2020;65:185004. [DOI: 10.1088/1361-6560/ab9702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
205 Akhavanallaf A, Shiri I, Arabi H, Zaidi H. Whole-body voxel-based internal dosimetry using deep learning. Eur J Nucl Med Mol Imaging 2021;48:670-82. [PMID: 32875430 DOI: 10.1007/s00259-020-05013-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
206 Vukmirovic D, Seymour C, Mothersill C. Reprint of: Deciphering and simulating models of radiation genotoxicity with CRISPR/Cas9 systems. Mutat Res Rev Mutat Res 2020;785:108318. [PMID: 32800271 DOI: 10.1016/j.mrrev.2020.108318] [Reference Citation Analysis]
207 Chen Z, Yao N, Zhang S, Song Y, Shao Q, Gu H, Ma J, Chen B, Zhao H, Tian Y. Identification of critical radioresistance genes in esophageal squamous cell carcinoma by whole-exome sequencing. Ann Transl Med 2020;8:998. [PMID: 32953798 DOI: 10.21037/atm-20-5196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
208 Rühle A, Grosu AL, Wiedenmann N, Mix M, Stoian R, Niedermann G, Baltas D, Werner M, Weber WA, Kayser G, Nicolay NH. Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation. Theranostics 2020;10:9395-406. [PMID: 32802199 DOI: 10.7150/thno.48392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
209 Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Radiotheranostics: a roadmap for future development. Lancet Oncol 2020;21:e146-56. [PMID: 32135118 DOI: 10.1016/S1470-2045(19)30821-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 23.7] [Reference Citation Analysis]
210 Kang M, Pang D. Commissioning and beam characterization of the first gantry-mounted accelerator pencil beam scanning proton system. Med Phys 2020;47:3496-510. [PMID: 31840264 DOI: 10.1002/mp.13972] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
211 Redalen KR, Thorwarth D. Future directions on the merge of quantitative imaging and artificial intelligence in radiation oncology. Phys Imaging Radiat Oncol 2020;15:44-5. [PMID: 33458325 DOI: 10.1016/j.phro.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 Marples B, Kerns S. Oncology Scan: Radiation Biology and Genomic Predictors of Response. Int J Radiat Oncol Biol Phys 2020;107:393-7. [PMID: 32531379 DOI: 10.1016/j.ijrobp.2020.04.008] [Reference Citation Analysis]
213 Nenoff L, Matter M, Jarhall AG, Winterhalter C, Gorgisyan J, Josipovic M, Persson GF, Munck af Rosenschold P, Weber DC, Lomax AJ, Albertini F. Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption? International Journal of Radiation Oncology*Biology*Physics 2020;107:747-55. [DOI: 10.1016/j.ijrobp.2020.03.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
214 Baumann M, Ebert N, Kurth I, Bacchus C, Overgaard J. What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond. Mol Oncol 2020;14:1577-85. [PMID: 32463984 DOI: 10.1002/1878-0261.12731] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
215 Grégoire V, Guckenberger M, Haustermans K, Lagendijk JJW, Ménard C, Pötter R, Slotman BJ, Tanderup K, Thorwarth D, van Herk M, Zips D. Image guidance in radiation therapy for better cure of cancer. Mol Oncol 2020;14:1470-91. [PMID: 32536001 DOI: 10.1002/1878-0261.12751] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
216 Cirillo G, Peitzsch C, Vittorio O, Curcio M, Farfalla A, Voli F, Dubrovska A, Iemma F, Kavallaris M, Hampel S. When polymers meet carbon nanostructures: expanding horizons in cancer therapy. Future Med Chem 2019;11:2205-31. [PMID: 31538523 DOI: 10.4155/fmc-2018-0540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
217 Busk M, Overgaard J, Horsman MR. Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. Semin Nucl Med 2020;50:562-83. [PMID: 33059825 DOI: 10.1053/j.semnuclmed.2020.05.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
218 Suckert T, Rassamegevanon T, Müller J, Dietrich A, Graja A, Reiche M, Löck S, Krause M, Beyreuther E, von Neubeck C. Applying Tissue Slice Culture in Cancer Research-Insights from Preclinical Proton Radiotherapy. Cancers (Basel) 2020;12:E1589. [PMID: 32560230 DOI: 10.3390/cancers12061589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
219 Saini G, Shukla R, Sood KS, Shukla SK, Chandra R. Role of Proton Beam Therapy in Current Day Radiation Oncology Practice. Asian Journal of Oncology 2020;06:097-106. [DOI: 10.1055/s-0040-1713703] [Reference Citation Analysis]
220 Kumar P, Dhabekar B, Sharma SD, Mishra DR, Rawat NS, Kadam S, Chaudhari S, Chandola RM, Agrawal S. Relative energy response of indigenously developed optically stimulated luminescence dosimeters Al2 O3 :C, LiMgPO4 :B and LiCaAlF6 :Eu,Y in therapeutic photon and electron beams. Luminescence 2020;35:1217-22. [PMID: 32515166 DOI: 10.1002/bio.3832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
221 Cui Y, Sun G, Li Y, Tang A, Zhu L, Kong D. DNA‐Based pH‐Responsive Core–Shell Drug Nanocarrier for Tumor‐Targeted Chemo‐Photodynamic Therapy. Adv Mater Interfaces 2020;7:2000292. [DOI: 10.1002/admi.202000292] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
222 Chua CYX, Ho J, Demaria S, Ferrari M, Grattoni A. Emerging Technologies for Local Cancer Treatment. Adv Therap 2020;3:2000027. [DOI: 10.1002/adtp.202000027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
223 Nenoff L, Ribeiro CO, Matter M, Hafner L, Josipovic M, Langendijk JA, Persson GF, Walser M, Weber DC, Lomax AJ, Knopf A, Albertini F, Zhang Y. Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy. Radiotherapy and Oncology 2020;147:178-85. [DOI: 10.1016/j.radonc.2020.04.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
224 Lazzaroni S, Liosi G, Mariani M, Dondi D. An innovative Fe3+ selective ligand for Fricke-gel dosimeter. Radiation Physics and Chemistry 2020;171:108733. [DOI: 10.1016/j.radphyschem.2020.108733] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
225 Borges da Silva E, Brayner Cavalcanti M, Ferreira Da Silva CS, de Salazar E Fernandes T, Azevedo Melo J, Lucena L, Maciel Netto A, Amaral A. Micronucleus assay for predicting side effects of radiotherapy for cervical cancer. Biotech Histochem 2021;96:60-6. [PMID: 32436746 DOI: 10.1080/10520295.2020.1759143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Kang J, Coates JT, Strawderman RL, Rosenstein BS, Kerns SL. Genomics models in radiotherapy: From mechanistic to machine learning. Med Phys 2020;47. [DOI: 10.1002/mp.13751] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
227 De Michino S, Aparnathi M, Rostami A, Lok BH, Bratman SV. The Utility of Liquid Biopsies in Radiation Oncology. Int J Radiat Oncol Biol Phys 2020;107:873-86. [PMID: 32417410 DOI: 10.1016/j.ijrobp.2020.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
228 van der Heijden M, Essers PBM, Verhagen CVM, Willems SM, Sanders J, de Roest RH, Vossen DM, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. Radiother Oncol 2020;147:186-94. [PMID: 32413532 DOI: 10.1016/j.radonc.2020.05.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
229 Vukmirovic D, Seymour C, Mothersill C. Deciphering and simulating models of radiation genotoxicity with CRISPR/Cas9 systems. Mutat Res Rev Mutat Res 2020;783:108298. [PMID: 32386748 DOI: 10.1016/j.mrrev.2020.108298] [Reference Citation Analysis]
230 Zeggini E, Baumann M, Götz M, Herzig S, Hrabe de Angelis M, Tschöp MH. Biomedical Research Goes Viral: Dangers and Opportunities. Cell 2020;181:1189-93. [PMID: 32442404 DOI: 10.1016/j.cell.2020.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Wang J, Li Z, Wang Z, Yu Y, Li D, Li B, Ding J. Nanomaterials for Combinational Radio–Immuno Oncotherapy. Adv Funct Mater 2020;30:1910676. [DOI: 10.1002/adfm.201910676] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
232 Zhao Z, Zhao J, Song K, Hussain A, Du Q, Dong Y, Liu J, Yang X. Joint DBN and Fuzzy C-Means unsupervised deep clustering for lung cancer patient stratification. Engineering Applications of Artificial Intelligence 2020;91:103571. [DOI: 10.1016/j.engappai.2020.103571] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
233 Shusharina N, Söderberg J, Edmunds D, Löfman F, Shih H, Bortfeld T. Automated delineation of the clinical target volume using anatomically constrained 3D expansion of the gross tumor volume. Radiotherapy and Oncology 2020;146:37-43. [DOI: 10.1016/j.radonc.2020.01.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
234 Meehan J, Gray M, Martínez-Pérez C, Kay C, Pang LY, Fraser JA, Poole AV, Kunkler IH, Langdon SP, Argyle D, Turnbull AK. Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front Oncol 2020;10:628. [PMID: 32391281 DOI: 10.3389/fonc.2020.00628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
235 Magalhaes Martins P, Dal Bello R, Ackermann B, Brons S, Hermann G, Kihm T, Seco J. PIBS: Proton and ion beam spectroscopy for in vivo measurements of oxygen, carbon, and calcium concentrations in the human body. Sci Rep 2020;10:7007. [PMID: 32332815 DOI: 10.1038/s41598-020-63215-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
236 Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers (Basel) 2020;12:E957. [PMID: 32294976 DOI: 10.3390/cancers12040957] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
237 Krause M, Alsner J, Linge A, Bütof R, Löck S, Bristow R. Specific requirements for translation of biological research into clinical radiation oncology. Mol Oncol 2020;14:1569-76. [PMID: 32175659 DOI: 10.1002/1878-0261.12671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
238 Combs SE, Belka C, Niyazi M, Corradini S, Pigorsch S, Wilkens J, Grosu AL, Guckenberger M, Ganswindt U, Bernhardt D. First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Radiat Oncol 2020;15:74. [PMID: 32264908 DOI: 10.1186/s13014-020-01527-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
239 Arndt C, Loureiro LR, Feldmann A, Jureczek J, Bergmann R, Máthé D, Hegedüs N, Berndt N, Koristka S, Mitwasi N, Fasslrinner F, Lamprecht C, Kegler A, Hoffmann A, Bartsch T, Köseer AS, Egan G, Schmitz M, Hořejší V, Krause M, Dubrovska A, Bachmann M. UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells. Oncoimmunology 2020;9:1743036. [PMID: 32426176 DOI: 10.1080/2162402X.2020.1743036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
240 Schmidt S, Linge A, Grosser M, Lohaus F, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S; German Cancer Consortium Radiation Oncology Group. Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. J Mol Diagn 2020;22:801-10. [PMID: 32247864 DOI: 10.1016/j.jmoldx.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
241 Xu J, Saklatvala R, Mittal S, Deshmukh S, Procopio A. Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli-an Industry Perspective. Adv Sci (Weinh) 2020;7:1903394. [PMID: 32328428 DOI: 10.1002/advs.201903394] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
242 Saksø M, Jensen K, Andersen M, Hansen CR, Eriksen JG, Overgaard J. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity. Radiother Oncol 2020;148:65-72. [PMID: 32335364 DOI: 10.1016/j.radonc.2020.03.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
243 Fiorino C, Guckemberger M, Schwarz M, van der Heide UA, Heijmen B. Technology-driven research for radiotherapy innovation. Mol Oncol 2020;14:1500-13. [PMID: 32124546 DOI: 10.1002/1878-0261.12659] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
244 Wohlfahrt P, Möhler C, Enghardt W, Krause M, Kunath D, Menkel S, Troost EGC, Greilich S, Richter C. Refinement of the Hounsfield look‐up table by retrospective application of patient‐specific direct proton stopping‐power prediction from dual‐energy CT. Med Phys 2020;47:1796-806. [DOI: 10.1002/mp.14085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
245 Corrao G, Marvaso G, Ferrara R, Lo Russo G, Gugliandolo SG, Piperno G, Spaggiari L, De Marinis F, Orecchia R, Garassino MC, Jereczek-Fossa BA. Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases. Lung Cancer 2020;142:70-9. [PMID: 32120227 DOI: 10.1016/j.lungcan.2020.02.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
246 Zschaeck S, Li Y, Bütof R, Lili C, Hua W, Troost ECG, Beck M, Amthauer H, Kaul D, Kotzerke J, Baur ADJ, Ghadjar P, Baumann M, Krause M, Hofheinz F. Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer. Int J Cancer 2020;147:1427-36. [PMID: 32010957 DOI: 10.1002/ijc.32897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
247 Goedegebuure RSA, Vonk C, Kooij LP, Derks S, Thijssen VLJL. Combining Radiation Therapy With Interferons: Back to the Future. Int J Radiat Oncol Biol Phys 2020;108:56-69. [PMID: 32068114 DOI: 10.1016/j.ijrobp.2020.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Do M, Stinson K, George R. Reflectance structured illumination imaging of internalized cerium oxide nanoparticles modulating dose-dependent reactive oxygen species in breast cancer cells. Biochem Biophys Rep 2020;22:100745. [PMID: 32099911 DOI: 10.1016/j.bbrep.2020.100745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
249 Saksø M, Primdahl H, Johansen J, Nowicka-Matus K, Overgaard J; DAHANCA. DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051). Acta Oncol 2020;59:208-11. [PMID: 31805799 DOI: 10.1080/0284186X.2019.1695065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
250 Sun Q, Klaseboer E, Yuffa AJ, Chan DYC. Field-only surface integral equations: scattering from a perfect electric conductor. J Opt Soc Am A Opt Image Sci Vis 2020;37:276-83. [PMID: 32118908 DOI: 10.1364/JOSAA.378665] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
251 Dutz A, Agolli L, Bütof R, Valentini C, Baumann M, Lühr A, Löck S, Krause M. Neurocognitive function and quality of life after proton beam therapy for brain tumour patients. Radiotherapy and Oncology 2020;143:108-16. [DOI: 10.1016/j.radonc.2019.12.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
252 Flood BA, Higgs EF, Li S, Luke JJ, Gajewski TF. STING pathway agonism as a cancer therapeutic. Immunol Rev 2019;290:24-38. [PMID: 31355488 DOI: 10.1111/imr.12765] [Cited by in Crossref: 125] [Cited by in F6Publishing: 130] [Article Influence: 41.7] [Reference Citation Analysis]
253 van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol 2019;9:1470. [PMID: 31998639 DOI: 10.3389/fonc.2019.01470] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
254 Schneider K, Ebert N, Kurth I, Baumann M. Preclinical In Vivo Evaluation of Novel Radiosensitizers by Local Tumor Control Experiments. Cancer Drug Discovery and Development 2020. [DOI: 10.1007/978-3-030-49701-9_7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
255 Gopal P, Castrillon JA, Abazeed ME. Mapping the Radiogenome of Human Cancers. Cancer Drug Discovery and Development 2020. [DOI: 10.1007/978-3-030-49701-9_3] [Reference Citation Analysis]
256 Binkley MS, Diehn M, Eke I, Willers H. Mechanisms and Markers of Clinical Radioresistance. Cancer Drug Discovery and Development 2020. [DOI: 10.1007/978-3-030-49701-9_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Dosch H, Adam G, Grosu A, Purschke M. Einleitung. Klassische Texte der Wissenschaft 2020. [DOI: 10.1007/978-3-662-61350-4_2] [Reference Citation Analysis]
258 Marples B, Wilson GD. Predicting Outcome using Genomic-Based Liquid Biomarkers. International Journal of Radiation Oncology*Biology*Physics 2020;106:1-4. [DOI: 10.1016/j.ijrobp.2019.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
259 Overgaard J, Baumann M. Four decades with ESTRO. Radiotherapy and Oncology 2020;142:1-5. [DOI: 10.1016/j.radonc.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
260 Rosenfeld A, Alnaghy S, Petasecca M, Cutajar D, Lerch M, Pospisil S, Giacometti V, Schulte R, Rosso V, Würl M, Granja C, Martišíková M, Parodi K. Medipix detectors in radiation therapy for advanced quality-assurance. Radiation Measurements 2020;130:106211. [DOI: 10.1016/j.radmeas.2019.106211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
261 Willers H, Eke I. Introduction to Molecular Targeted Radiosensitizers: Opportunities and Challenges. Cancer Drug Discovery and Development 2020. [DOI: 10.1007/978-3-030-49701-9_1] [Reference Citation Analysis]
262 Dunne EM, Sahgal A, Lo SS, Bergman A, Kosztyla R, Dea N, Chang EL, Chang UK, Chao ST, Faruqi S, Ghia AJ, Redmond KJ, Soltys SG, Liu MC. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT). Radiother Oncol 2020;145:21-9. [PMID: 31874346 DOI: 10.1016/j.radonc.2019.11.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
263 Rodriguez-Ruiz ME, Vitale I, Harrington KJ, Melero I, Galluzzi L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nat Immunol 2020;21:120-34. [PMID: 31873291 DOI: 10.1038/s41590-019-0561-4] [Cited by in Crossref: 115] [Cited by in F6Publishing: 124] [Article Influence: 28.8] [Reference Citation Analysis]
264 Zhang X, Zhong L, Zhang B, Zhang L, Du H, Lu L, Zhang S, Yang W, Feng Q. The effects of volume of interest delineation on MRI-based radiomics analysis: evaluation with two disease groups. Cancer Imaging 2019;19:89. [PMID: 31864421 DOI: 10.1186/s40644-019-0276-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
265 Wang H, Li J, Wang Y, Gong X, Xu X, Wang J, Li Y, Sha X, Zhang Z. Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy. J Control Release. 2020;319:25-45. [PMID: 31862359 DOI: 10.1016/j.jconrel.2019.12.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
266 Parodi K. Latest developments in in-vivo imaging for proton therapy. Br J Radiol 2020;93:20190787. [PMID: 31794249 DOI: 10.1259/bjr.20190787] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
267 Thorwarth D, Muren L. Imaging science and development in modern high-precision radiotherapy. Phys Imaging Radiat Oncol 2019;12:63-6. [PMID: 33458297 DOI: 10.1016/j.phro.2019.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
268 Tang X. The role of artificial intelligence in medical imaging research. BJR Open. 2020;2:20190031. [PMID: 33178962 DOI: 10.1259/bjro.20190031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
269 Hall WA. Opportunities and Challenges of Genomically Guided Decision Making for Patients With Prostate Cancer. Pract Radiat Oncol 2020;10:93-4. [PMID: 31760164 DOI: 10.1016/j.prro.2019.11.006] [Reference Citation Analysis]
270 Eulitz J, Lutz B, Wohlfahrt P, Dutz A, Enghardt W, Karpowitz C, Krause M, Troost EGC, Lühr A. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy. Phys Med Biol 2019;64:225020. [PMID: 31374558 DOI: 10.1088/1361-6560/ab3841] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
271 Deycmar S, Faccin E, Kazimova T, Knobel PA, Telarovic I, Tschanz F, Waller V, Winkler R, Yong C, Zingariello D, Pruschy M. The relative biological effectiveness of proton irradiation in dependence of DNA damage repair. Br J Radiol 2020;93:20190494. [PMID: 31687835 DOI: 10.1259/bjr.20190494] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
272 Wang Y, Zhao M, He S, Luo Y, Zhao Y, Cheng J, Gong Y, Xie J, Wang Y, Hu B, Tian L, Liu X, Li C, Huang Q. Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway. J Exp Clin Cancer Res 2019;38:461. [PMID: 31706322 DOI: 10.1186/s13046-019-1423-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
273 Zeng WQ, Feng W, Xie L, Zhang CC, Yu W, Cai XW, Fu XL. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study. Lung 2019;197:741-51. [PMID: 31705271 DOI: 10.1007/s00408-019-00284-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
274 Burigo LN, Oborn BM. MRI-guided proton therapy planning: accounting for an inline MRI fringe field. Phys Med Biol 2019;64:215015. [PMID: 31509819 DOI: 10.1088/1361-6560/ab436a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
275 Wohlfahrt P, Möhler C, Troost EG, Greilich S, Richter C. Dual-Energy Computed Tomography to Assess Intra- and Inter-Patient Tissue Variability for Proton Treatment Planning of Patients With Brain Tumor. International Journal of Radiation Oncology*Biology*Physics 2019;105:504-13. [DOI: 10.1016/j.ijrobp.2019.06.2529] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
276 Yuan TZ, Zhan ZJ, Qian CN. New frontiers in proton therapy: applications in cancers. Cancer Commun (Lond) 2019;39:61. [PMID: 31640788 DOI: 10.1186/s40880-019-0407-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
277 Vernuccio F, Godfrey D, Meyer M, Williamson HV, Salama JK, Niedzwiecki D, Stephens SJ, Ronald J, Palta M, Marin D. Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria. AJR Am J Roentgenol 2019;213:1232-9. [PMID: 31613663 DOI: 10.2214/AJR.18.20842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
278 Zhang J, Cui YX, Feng XN, Cheng M, Tang AN, Kong DM. pH-Controlled Intracellular in Situ Reversible Assembly of a Photothermal Agent for Smart Chemo-Photothermal Synergetic Therapy and ATP Imaging. ACS Appl Mater Interfaces 2019;11:39624-32. [PMID: 31573175 DOI: 10.1021/acsami.9b14186] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
279 Dünker N, Jendrossek V. Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research. Cancers (Basel) 2019;11:E1499. [PMID: 31591362 DOI: 10.3390/cancers11101499] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
280 Caravatta L, Fiorica F, Rosa C, Boldrini L, Alitto AR, Nardangeli A, Dionisi F, Bianco L, Munoz F, Lupattelli M, Mantello G, Genovesi D, Massaccesi M; Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Strahlenther Onkol 2020;196:1-14. [DOI: 10.1007/s00066-019-01519-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Je E, Lee HH, Duan X, Li B, Jia X, Yang M. Optimal energy selection for proton stopping-power-ratio estimation using dual-energy CT-based monoenergetic imaging. Phys Med Biol 2019;64:195015. [DOI: 10.1088/1361-6560/ab3dec] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
282 Parodi K, Assmann W, Belka C, Bortfeldt J, Clevert DA, Dedes G, Kalunga R, Kundel S, Kurichiyanil N, Lämmer P, Lascaud J, Lauber K, Lovatti G, Meyer S, Nitta M, Pinto M, Safari MJ, Schnürle K, Schreiber J, Thirolf PG, Wieser HP, Würl M. Towards a novel small animal proton irradiation platform: the SIRMIO project. Acta Oncol 2019;58:1470-5. [PMID: 31271091 DOI: 10.1080/0284186X.2019.1630752] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
283 Eulitz J, Troost EGC, Raschke F, Schulz E, Lutz B, Dutz A, Löck S, Wohlfahrt P, Enghardt W, Karpowitz C, Krause M, Lühr A. Predicting late magnetic resonance image changes in glioma patients after proton therapy. Acta Oncol 2019;58:1536-9. [PMID: 31303083 DOI: 10.1080/0284186X.2019.1631477] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
284 Saksø M, Andersen E, Bentzen J, Andersen M, Johansen J, Primdahl H, Overgaard J, Eriksen JG. A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma. Acta Oncol 2019;58:1495-501. [PMID: 31519130 DOI: 10.1080/0284186X.2019.1658897] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
285 Manem VS, Lambie M, Smith I, Smirnov P, Kofia V, Freeman M, Koritzinsky M, Abazeed ME, Haibe-Kains B, Bratman SV. Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy. Cancer Res 2019;79:6227-37. [PMID: 31558563 DOI: 10.1158/0008-5472.CAN-19-0179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
286 Manem VS, Dhawan A. RadiationGeneSigDB: a database of oxic and hypoxic radiation response gene signatures and their utility in pre-clinical research. Br J Radiol 2019;92:20190198. [PMID: 31538514 DOI: 10.1259/bjr.20190198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
287 Cammarata FP, Torrisi F, Forte GI, Minafra L, Bravatà V, Pisciotta P, Savoca G, Calvaruso M, Petringa G, Cirrone GAP, Fallacara AL, Maccari L, Botta M, Schenone S, Parenti R, Cuttone G, Russo G. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line. Int J Mol Sci 2019;20:E4745. [PMID: 31554327 DOI: 10.3390/ijms20194745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
288 Clark CH, Gagliardi G, Heijmen B, Malicki J, Thorwarth D, Verellen D, Muren LP. Adapting training for medical physicists to match future trends in radiation oncology. Phys Imaging Radiat Oncol 2019;11:71-5. [PMID: 33458282 DOI: 10.1016/j.phro.2019.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
289 Wong WW, Jackson RK, Liew LP, Dickson BD, Cheng GJ, Lipert B, Gu Y, Hunter FW, Wilson WR, Hay MP. Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361. Biochem Pharmacol 2019;169:113641. [PMID: 31541630 DOI: 10.1016/j.bcp.2019.113641] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
290 Willers H, Keane FK, Kamran SC. Toward a New Framework for Clinical Radiation Biology. Hematol Oncol Clin North Am 2019;33:929-45. [PMID: 31668212 DOI: 10.1016/j.hoc.2019.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
291 Knez D, Schnedlitz M, Lasserus M, Hauser AW, Ernst WE, Hofer F, Kothleitner G. The impact of swift electrons on the segregation of Ni-Au nanoalloys. Appl Phys Lett 2019;115:123103. [DOI: 10.1063/1.5093472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
292 Bogowicz M, Vuong D, Huellner MW, Pavic M, Andratschke N, Gabrys HS, Guckenberger M, Tanadini-Lang S. CT radiomics and PET radiomics: ready for clinical implementation? Q J Nucl Med Mol Imaging 2019;63:355-70. [PMID: 31527578 DOI: 10.23736/S1824-4785.19.03192-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
293 Liu C, Lu Z, Ma L, Wang L, Jin X, Si W. A modality conversion approach to MV‐DRs and KV‐DRRs registration using information bottlenecked conditional generative adversarial network. Med Phys 2019;46:4575-87. [DOI: 10.1002/mp.13770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
294 Nourollahi S, Ghate A, Kim M. Optimal modality selection in external beam radiotherapy. Math Med Biol 2019;36:361-80. [PMID: 30192934 DOI: 10.1093/imammb/dqy013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
295 Cho Y, Park S, Byun HK, Lee CG, Cho J, Hong MH, Kim HR, Cho BC, Kim S, Park J, Yoon HI. Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2019;105:1065-73. [PMID: 31476418 DOI: 10.1016/j.ijrobp.2019.08.047] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]
296 Bai Y, Wang Y, Zhang X, Fu J, Xing X, Wang C, Gao L, Liu Y, Shi L. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy. Int J Pharm 2019;570:118636. [PMID: 31446027 DOI: 10.1016/j.ijpharm.2019.118636] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
297 Rassamegevanon T, Löck S, Baumann M, Krause M, von Neubeck C. Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX. Radiother Oncol 2019;139:94-100. [PMID: 31445839 DOI: 10.1016/j.radonc.2019.06.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
298 Gurtner K, Kryzmien Z, Koi L, Wang M, Benes CH, Hering S, Willers H, Baumann M, Krause M. Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo. Int J Cancer 2020;147:472-7. [PMID: 31359406 DOI: 10.1002/ijc.32598] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
299 Komatsu S, Oike T, Komatsu Y, Kubota Y, Sakai M, Matsui T, Nuryadi E, Permata TBM, Sato H, Kawamura H, Okamoto M, Kaminuma T, Murata K, Okano N, Hirota Y, Ohno T, Saitoh JI, Shibata A, Nakano T. Deep learning-assisted literature mining for in vitro radiosensitivity data. Radiother Oncol 2019;139:87-93. [PMID: 31431384 DOI: 10.1016/j.radonc.2019.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
300 Rackwitz T, Debus J. Clinical applications of proton and carbon ion therapy. Semin Oncol 2019;46:226-32. [PMID: 31451309 DOI: 10.1053/j.seminoncol.2019.07.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
301 Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet Oncology 2019;20:e452-63. [DOI: 10.1016/s1470-2045(19)30171-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 21.8] [Reference Citation Analysis]
302 Meneceur S, Löck S, Gudziol V, Hering S, Bütof R, Rehm M, Baumann M, Krause M, von Neubeck C. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens. Radiotherapy and Oncology 2019;137:24-31. [DOI: 10.1016/j.radonc.2019.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
303 F.i. Osman A. Radiation Oncology in the Era of Big Data and Machine Learning for Precision Medicine. Artificial Intelligence - Applications in Medicine and Biology 2019. [DOI: 10.5772/intechopen.84629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
304 Pacelli R, Caroprese M, Palma G, Oliviero C, Clemente S, Cella L, Conson M. Technological evolution of radiation treatment: Implications for clinical applications. Semin Oncol 2019;46:193-201. [PMID: 31395286 DOI: 10.1053/j.seminoncol.2019.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
305 Lee SH, Cho HH, Lee HY, Park H. Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer. Cancer Imaging 2019;19:54. [PMID: 31349872 DOI: 10.1186/s40644-019-0239-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
306 Durante M, Formenti S. Harnessing radiation to improve immunotherapy: better with particles? Br J Radiol 2020;93:20190224. [PMID: 31317768 DOI: 10.1259/bjr.20190224] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
307 García-Fernández GF, Cevallos-Robalino LE, García-Baonza R, Gallego E, Vega-Carrillo HR, Guzman-García KA, Lorente A, Ibáñez S. Monte Carlo characterization and benchmarking of extended range REM meters for its application in shielding and radiation area monitoring in Compact Proton Therapy Centers (CPTC). Appl Radiat Isot 2019;152:115-26. [PMID: 31295682 DOI: 10.1016/j.apradiso.2019.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
308 Jung SY, Nam KY, Park JI, Song KH, Ahn J, Park JK, Um HD, Hwang SG, Choi SU, Song JY. Radiosensitizing Effect of Novel Phenylpyrimidine Derivatives on Human Lung Cancer Cells via Cell Cycle Perturbation. J Pharmacol Exp Ther 2019;370:514-27. [PMID: 31253693 DOI: 10.1124/jpet.119.257717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Wéra AC, Lobbens A, Stoyanov M, Lucas S, Michiels C. Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation. Cell Cycle 2019;18:1770-83. [PMID: 31238782 DOI: 10.1080/15384101.2019.1632640] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
310 Schulz A, Meyer F, Dubrovska A, Borgmann K. Cancer Stem Cells and Radioresistance: DNA Repair and Beyond. Cancers (Basel) 2019;11:E862. [PMID: 31234336 DOI: 10.3390/cancers11060862] [Cited by in Crossref: 116] [Cited by in F6Publishing: 126] [Article Influence: 29.0] [Reference Citation Analysis]
311 Pérez-Medina C, Hak S, Reiner T, Fayad ZA, Nahrendorf M, Mulder WJM. Integrating nanomedicine and imaging. Philos Trans A Math Phys Eng Sci 2017;375:20170110. [PMID: 29038380 DOI: 10.1098/rsta.2017.0110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
312 Meißner R, Kočišek J, Feketeová L, Fedor J, Fárník M, Limão-Vieira P, Illenberger E, Denifl S. Low-energy electrons transform the nimorazole molecule into a radiosensitiser. Nat Commun 2019;10:2388. [PMID: 31160602 DOI: 10.1038/s41467-019-10340-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
313 Dutz A, Agolli L, Baumann M, Troost EGC, Krause M, Hölscher T, Löck S. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis. Acta Oncol 2019;58:916-25. [PMID: 30882264 DOI: 10.1080/0284186X.2019.1581373] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
314 Durante M, Flanz J. Charged particle beams to cure cancer: Strengths and challenges. Seminars in Oncology 2019;46:219-25. [DOI: 10.1053/j.seminoncol.2019.07.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
315 Arimura H, Soufi M, Kamezawa H, Ninomiya K, Yamada M. Radiomics with artificial intelligence for precision medicine in radiation therapy. J Radiat Res 2019;60:150-7. [PMID: 30247662 DOI: 10.1093/jrr/rry077] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 11.3] [Reference Citation Analysis]
316 Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, Thorwarth D, Riess O, Zips D, Schroeder C, Welz S. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol 2019;195:771-9. [PMID: 31123786 DOI: 10.1007/s00066-019-01478-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
317 Wang Z, Tang Y, Tan Y, Wei Q, Yu W. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities. Cell Commun Signal 2019;17:47. [PMID: 31101063 DOI: 10.1186/s12964-019-0362-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 13.5] [Reference Citation Analysis]
318 Ajdari A, Niyazi M, Nicolay NH, Thieke C, Jeraj R, Bortfeld T. Towards optimal stopping in radiation therapy. Radiotherapy and Oncology 2019;134:96-100. [DOI: 10.1016/j.radonc.2019.01.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
319 Das CK, Mandal M, Kögel D. Pro-survival autophagy and cancer cell resistance to therapy. Cancer Metastasis Rev 2018;37:749-66. [PMID: 29536228 DOI: 10.1007/s10555-018-9727-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 18.8] [Reference Citation Analysis]
320 Sun GY, Du YC, Cui YX, Wang J, Li XY, Tang AN, Kong DM. Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of pH-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy. ACS Appl Mater Interfaces 2019;11:14684-92. [PMID: 30942569 DOI: 10.1021/acsami.9b05358] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
321 Rodriguez-Ruiz ME, Yamazaki T, Buqué A, Bloy N, Silva VAO, Stafford L, Sato A, Galluzzi L. Monitoring abscopal responses to radiation in mice. Methods Enzymol 2020;635:111-25. [PMID: 32122540 DOI: 10.1016/bs.mie.2019.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Falls KC, Sharma RA, Lawrence YR, Amos RA, Advani SJ, Ahmed MM, Vikram B, Coleman CN, Prasanna PG. Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico. Radiat Res 2018;190:350-60. [PMID: 30280985 DOI: 10.1667/RR15121.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
323 DuRoss AN, Neufeld MJ, Rana S, Thomas CR Jr, Sun C. Integrating nanomedicine into clinical radiotherapy regimens. Adv Drug Deliv Rev 2019;144:35-56. [PMID: 31279729 DOI: 10.1016/j.addr.2019.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
324 Kirsch DG. Current Opportunities and Future Vision of Precision Medicine in Radiation Oncology. Int J Radiat Oncol Biol Phys 2018;101:267-70. [PMID: 29726356 DOI: 10.1016/j.ijrobp.2017.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
325 Coleman CN, Prasanna PGS, Bernhard EJ, Buchsbaum JC, Ahmed MM, Capala J, Obcemea C, Deye JA, Pistenmma DA, Vikram B, Bernier J, Dosanjh M. Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism. Int J Radiat Oncol Biol Phys 2018;101:250-3. [PMID: 29726348 DOI: 10.1016/j.ijrobp.2018.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
326 Lee HHC, Li B, Duan X, Zhou L, Jia X, Yang M. Systematic analysis of the impact of imaging noise on dual-energy CT-based proton stopping power ratio estimation. Med Phys 2019;46:2251-63. [PMID: 30883827 DOI: 10.1002/mp.13493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
327 Peitzsch C, Kurth I, Ebert N, Dubrovska A, Baumann M. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology. Int J Radiat Biol 2019;95:900-11. [PMID: 30897014 DOI: 10.1080/09553002.2019.1589023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
328 Scherman J, Appelt AL, Yu J, Persson GF, Nygård L, Langendijk JA, Bentzen SM, Vogelius IR. Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy. Int J Part Ther 2019;5:24-32. [PMID: 31788505 DOI: 10.14338/IJPT-18-00038.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
329 Linge A, Schmidt S, Lohaus F, Krenn C, Bandurska-Luque A, Platzek I, von Neubeck C, Appold S, Nowak A, Gudziol V, Buchholz F, Baretton GB, Baumann M, Löck S, Krause M. Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy. Clin Transl Radiat Oncol 2019;16:40-7. [PMID: 30993218 DOI: 10.1016/j.ctro.2019.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
330 Perumal V, Corica T, Dharmarajan AM, Sun Z, Dhaliwal SS, Dass CR, Dass J. Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives. Cancers (Basel) 2019;11:E367. [PMID: 30875950 DOI: 10.3390/cancers11030367] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
331 Löck S, Linge A, Seidlitz A, Bandurska-Luque A, Nowak A, Gudziol V, Buchholz F, Aust DE, Baretton GB, Zöphel K, Steinbach J, Kotzerke J, Overgaard J, Zips D, Krause M, Baumann M, Troost EGC. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy. Radiother Oncol 2019;135:43-50. [PMID: 31015169 DOI: 10.1016/j.radonc.2019.02.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
332 Reid P, Marcu LG, Olver I, Moghaddasi L, Staudacher AH, Bezak E. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiother Oncol 2019;135:1-12. [PMID: 31015153 DOI: 10.1016/j.radonc.2019.02.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
333 Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ. The Future of Radiobiology. J Natl Cancer Inst 2018;110:329-40. [PMID: 29126306 DOI: 10.1093/jnci/djx231] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 13.5] [Reference Citation Analysis]
334 Cubillos-mesías M, Troost EG, Lohaus F, Agolli L, Rehm M, Richter C, Stützer K. Including anatomical variations in robust optimization for head and neck proton therapy can reduce the need of adaptation. Radiotherapy and Oncology 2019;131:127-34. [DOI: 10.1016/j.radonc.2018.12.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
335 Sivasubramanian M, Chuang YC, Lo LW. Evolution of Nanoparticle-Mediated Photodynamic Therapy: From Superficial to Deep-Seated Cancers. Molecules 2019;24:E520. [PMID: 30709030 DOI: 10.3390/molecules24030520] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 13.0] [Reference Citation Analysis]
336 Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L, Faithfull S, Liu L, Meunier F, Ulrich C; European Academy of Cancer Sciences. Cancer survivorship: an integral part of Europe's research agenda. Mol Oncol 2019;13:624-35. [PMID: 30552794 DOI: 10.1002/1878-0261.12428] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 15.5] [Reference Citation Analysis]
337 Fahim Golestaneh A, Lecker LSM, Schlegel J, Nowrouzi A, Schwager C, Meister S, Weichert W, Debus J, Abdollahi A. Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication. Int J Cancer 2019;144:2774-81. [PMID: 30478850 DOI: 10.1002/ijc.32019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
338 Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD, Kong FS. Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients. J Cancer 2019;10:168-77. [PMID: 30662537 DOI: 10.7150/jca.26600] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
339 Dahl O, Dale JE, Brydøy M. Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment. Acta Oncol 2019;58:9-20. [PMID: 30632870 DOI: 10.1080/0284186X.2018.1554259] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
340 Dutz A, Lühr A, Agolli L, Troost EG, Krause M, Baumann M, Vermeren X, Geismar D, Schapira EF, Bussière M, Daly JE, Bussière MR, Timmermann B, Shih HA, Löck S. Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours. Radiotherapy and Oncology 2019;130:164-71. [DOI: 10.1016/j.radonc.2018.06.036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
341 Li W, Jiang Z, Chu K, Jin J, Ge Y, Cai J. A Noninvasive Method to Reduce Radiotherapy Positioning Error Caused by Respiration for Patients With Abdominal or Pelvic Cancers. Technol Cancer Res Treat 2019;18:1533033819825865. [PMID: 30803363 DOI: 10.1177/1533033819825865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
342 Sørensen BS, Andreassen CN, Alsner J. Molecular Biomarkers in Radiation Oncology. Radiation Oncology 2019. [DOI: 10.1007/978-3-319-52619-5_103-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
343 Nourollahi S, Ghate A, Kim M. Robust Modality Selection in Radiotherapy. Advances in Service Science 2019. [DOI: 10.1007/978-3-030-04726-9_2] [Reference Citation Analysis]
344 Joye I, Dirix P. Response Assessment. MRI for Radiotherapy 2019. [DOI: 10.1007/978-3-030-14442-5_6] [Reference Citation Analysis]
345 Ratnayake G, Bain AL, Fletcher N, Howard CB, Khanna KK, Thurecht KJ. RNA interference to enhance radiation therapy: Targeting the DNA damage response. Cancer Lett 2018;439:14-23. [PMID: 30240587 DOI: 10.1016/j.canlet.2018.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
346 Cordes N, Ney M, Beleites T, Aust D, Baretton G, Thames H, Baumann M, Krause M, Löck S, Appold S. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy. PLoS One 2018;13:e0209479. [PMID: 30571736 DOI: 10.1371/journal.pone.0209479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
347 Durante M. Proton beam therapy in Europe: more centres need more research. Br J Cancer 2019;120:777-8. [PMID: 30531831 DOI: 10.1038/s41416-018-0329-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
348 Locy H, de Mey S, de Mey W, De Ridder M, Thielemans K, Maenhout SK. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend. Front Immunol 2018;9:2909. [PMID: 30619273 DOI: 10.3389/fimmu.2018.02909] [Cited by in Crossref: 98] [Cited by in F6Publishing: 115] [Article Influence: 19.6] [Reference Citation Analysis]
349 Vanstalle M, Constanzo J, Finck C. Investigation of Optimal Physical Parameters for Precise Proton Irradiation of Orthotopic Tumors in Small Animals. Int J Radiat Oncol Biol Phys 2019;103:1241-50. [PMID: 30513379 DOI: 10.1016/j.ijrobp.2018.11.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
350 Oeck S, Szymonowicz K, Wiel G, Krysztofiak A, Lambert J, Koska B, Iliakis G, Timmermann B, Jendrossek V. Relating Linear Energy Transfer to the Formation and Resolution of DNA Repair Foci After Irradiation with Equal Doses of X-ray Photons, Plateau, or Bragg-Peak Protons. IJMS 2018;19:3779. [DOI: 10.3390/ijms19123779] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
351 Zou W, Dong L, Kevin Teo BK. Current State of Image Guidance in Radiation Oncology: Implications for PTV Margin Expansion and Adaptive Therapy. Semin Radiat Oncol 2018;28:238-47. [PMID: 29933883 DOI: 10.1016/j.semradonc.2018.02.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
352 Story MD, Wang J. Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy. Int J Part Ther 2018;5:94-102. [PMID: 30393751 DOI: 10.14338/IJPT-18-00027.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
353 Kurz C, Süss P, Arnsmeyer C, Haehnle J, Teichert K, Landry G, Hofmaier J, Exner F, Hille L, Kamp F, Thieke C, Ganswindt U, Valentini C, Hölscher T, Troost E, Krause M, Belka C, Küfer KH, Parodi K, Richter C. Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization. Z Med Phys 2019;29:216-28. [PMID: 30409729 DOI: 10.1016/j.zemedi.2018.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
354 Zhou C, Jones B, Moustafa M, Yang B, Brons S, Cao L, Dai Y, Schwager C, Chen M, Jaekel O, Chen L, Debus J, Abdollahi A. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model. Clin Transl Radiat Oncol 2019;14:25-32. [PMID: 30511024 DOI: 10.1016/j.ctro.2018.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
355 Boase NR, Smith ST, Masters K, Hosokawa K, Crowe SB, Trapp JV. Xylenol orange functionalised polymers to overcome diffusion in Fricke gel radiation dosimeters. Reactive and Functional Polymers 2018;132:81-8. [DOI: 10.1016/j.reactfunctpolym.2018.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
356 Andreassen C, Eriksen J, Jensen K, Hansen C, Sørensen B, Lassen P, Alsner J, Schack L, Overgaard J, Grau C. IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology 2018;86:91-9. [DOI: 10.1016/j.oraloncology.2018.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
357 Hamming-vrieze O, Navran A, Al-mamgani A, Vogel WV. Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review. Q J Nucl Med Mol Imaging 2018;62. [DOI: 10.23736/s1824-4785.18.03087-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
358 Jacobsen KM, Villadsen NL, Tørring T, Nielsen CB, Salomón T, Nielsen MM, Tsakos M, Sibbersen C, Scavenius C, Nielsen R, Christensen EI, Guerra PF, Bross P, Pedersen JS, Enghild JJ, Johannsen M, Frøkiær J, Overgaard J, Horsman MR, Busk M, Poulsen TB. APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells. Cell Chemical Biology 2018;25:1337-1349.e12. [DOI: 10.1016/j.chembiol.2018.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
359 Manem VS, Dhawan A. RadiationGeneSigDB: A database of oxic and hypoxic radiation response gene signatures and their utility in identification of hypoxia-regulated MicroRNA.. [DOI: 10.1101/455345] [Reference Citation Analysis]
360 Gray ME, Meehan J, Blair EO, Ward C, Langdon SP, Morrison LR, Marland JRK, Tsiamis A, Kunkler IH, Murray A, Argyle D. Biocompatibility of common implantable sensor materials in a tumor xenograft model. J Biomed Mater Res B Appl Biomater 2019;107:1620-33. [PMID: 30367816 DOI: 10.1002/jbm.b.34254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
361 Cabello G, Nwoko KC, Mingarelli M, Mclaughlin AC, Trembleau L, Feldmann J, Cuesta A, Smith TA. Physicochemical Tools: Toward a Detailed Understanding of the Architecture of Targeted Radiotherapy Nanoparticles. ACS Appl Bio Mater 2018;1:1639-46. [DOI: 10.1021/acsabm.8b00476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
362 Bandurska-Luque A, Löck S, Haase R, Richter C, Zöphel K, Abolmaali N, Seidlitz A, Appold S, Krause M, Steinbach J, Kotzerke J, Zips D, Baumann M, Troost EGC. FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients. Radiother Oncol 2019;130:97-103. [PMID: 30293643 DOI: 10.1016/j.radonc.2018.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
363 Mein S, Choi K, Kopp B, Tessonnier T, Bauer J, Ferrari A, Haberer T, Debus J, Abdollahi A, Mairani A. Fast robust dose calculation on GPU for high-precision 1H, 4He, 12C and 16O ion therapy: the FRoG platform. Sci Rep 2018;8:14829. [PMID: 30287930 DOI: 10.1038/s41598-018-33194-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
364 Meng Z, Chao Y, Zhou X, Liang C, Liu J, Zhang R, Cheng L, Yang K, Pan W, Zhu M, Liu Z. Near-Infrared-Triggered in Situ Gelation System for Repeatedly Enhanced Photothermal Brachytherapy with a Single Dose. ACS Nano 2018;12:9412-22. [PMID: 30148960 DOI: 10.1021/acsnano.8b04544] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 14.8] [Reference Citation Analysis]
365 Beyreuther E, Baumann M, Enghardt W, Helmbrecht S, Karsch L, Krause M, Pawelke J, Schreiner L, Schürer M, von Neubeck C, Lühr A. Research Facility for Radiobiological Studies at the University Proton Therapy Dresden. Int J Part Ther 2018;5:172-82. [PMID: 31773028 DOI: 10.14338/IJPT-18-00008.1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
366 Paganelli C, Meschini G, Molinelli S, Riboldi M, Baroni G. “Patient-specific validation of deformable image registration in radiation therapy: Overview and caveats”. Med Phys 2018;45:e908-22. [DOI: 10.1002/mp.13162] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 11.4] [Reference Citation Analysis]
367 Choi BJ, Jung KO, Graves EE, Pratx G. A gold nanoparticle system for the enhancement of radiotherapy and simultaneous monitoring of reactive-oxygen-species formation. Nanotechnology 2018;29:504001. [PMID: 30229748 DOI: 10.1088/1361-6528/aae272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
368 Jiang H, Wang H, De Ridder M. Targeting antioxidant enzymes as a radiosensitizing strategy. Cancer Lett 2018;438:154-64. [PMID: 30223069 DOI: 10.1016/j.canlet.2018.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
369 Renfrew A. Selective Activation of Transition-Metal Complexes in Medicine. Encyclopedia of Inorganic and Bioinorganic Chemistry 2018. [DOI: 10.1002/9781119951438.eibc2634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
370 Ibragimov B, Toesca D, Chang D, Yuan Y, Koong A, Xing L. Development of deep neural network for individualized hepatobiliary toxicity prediction after liver SBRT. Med Phys. 2018;45:4763-4774. [PMID: 30098025 DOI: 10.1002/mp.13122] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 13.8] [Reference Citation Analysis]
371 Rassamegevanon T, Löck S, Baumann M, Krause M, von Neubeck C. Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors. Int J Mol Sci 2018;19:E2616. [PMID: 30181446 DOI: 10.3390/ijms19092616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
372 Oria VO, Bronsert P, Thomsen AR, Föll MC, Zamboglou C, Hannibal L, Behringer S, Biniossek ML, Schreiber C, Grosu AL, Bolm L, Rades D, Keck T, Werner M, Wellner UF, Schilling O. Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance. Transl Oncol 2018;11:1307-22. [PMID: 30172883 DOI: 10.1016/j.tranon.2018.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
373 Bütof R, Hofheinz F, Zöphel K, Schmollack J, Jentsch C, Zschaeck S, Kotzerke J, van den Hoff J, Baumann M. Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma. J Nucl Med 2018:jnumed. [PMID: 30166358 DOI: 10.2967/jnumed.117.207670] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
374 Cho S, Lee B, Park W, Huang X, Kim DH. Photoperiodic Flower Mimicking Metallic Nanoparticles for Image-Guided Medicine Applications. ACS Appl Mater Interfaces 2018;10:27570-7. [PMID: 30086228 DOI: 10.1021/acsami.8b09596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
375 Leger S, Zwanenburg A, Pilz K, Zschaeck S, Zöphel K, Kotzerke J, Schreiber A, Zips D, Krause M, Baumann M, Troost EGC, Richter C, Löck S. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. Radiother Oncol 2019;130:10-7. [PMID: 30087056 DOI: 10.1016/j.radonc.2018.07.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
376 Ben Mihoub A, Larue L, Moussaron A, Youssef Z, Colombeau L, Baros F, Frochot C, Vanderesse R, Acherar S. Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment. Molecules 2018;23:E1936. [PMID: 30072672 DOI: 10.3390/molecules23081936] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
377 Deycmar S, Pruschy M. Combined Treatment Modalities for High-Energy Proton Irradiation: Exploiting Specific DNA Repair Dependencies. International Journal of Particle Therapy 2018;5:133-139. [DOI: 10.14338/ijpt-18-00020.1] [Reference Citation Analysis]
378 Shusharina N, Craft D, Chen Y, Shih H, Bortfeld T. The clinical target distribution: a probabilistic alternative to the clinical target volume. Phys Med Biol 2018;63:155001. [DOI: 10.1088/1361-6560/aacfb4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
379 Pötter R, Balosso J, Baumann M, Bert C, Davies J, Enghardt W, Fossati P, Harris S, Jones B, Krämer M, Mayer R, Mock U, Pullia M, Schreiner T, Dosanjh M, Debus J, Orecchia R, Georg D. Union of light ion therapy centers in Europe (ULICE EC FP7) – Objectives and achievements of joint research activities. Radiotherapy and Oncology 2018;128:83-100. [DOI: 10.1016/j.radonc.2018.04.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
380 Buontempo F, Orsini E, Zironi I, Isolan L, Cappellini A, Rapino S, Tartari A, Mostacci D, Cucchi G, Martelli AM, Sumini M, Castellani G. Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. PLoS One 2018;13:e0199312. [PMID: 29958291 DOI: 10.1371/journal.pone.0199312] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
381 Kirakci K, Zelenka J, Rumlová M, Martinčík J, Nikl M, Ruml T, Lang K. Octahedral molybdenum clusters as radiosensitizers for X-ray induced photodynamic therapy. J Mater Chem B 2018;6:4301-7. [PMID: 32254506 DOI: 10.1039/c8tb00893k] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
382 Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS. Machine Learning and Radiogenomics: Lessons Learned and Future Directions. Front Oncol 2018;8:228. [PMID: 29977864 DOI: 10.3389/fonc.2018.00228] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
383 Park S, Lee EJ, Rim CH, Seong J. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma. Yonsei Med J 2018;59:470-9. [PMID: 29749129 DOI: 10.3349/ymj.2018.59.4.470] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
384 Liu C, Huang M, Ma L, Lu Z. Synthesising KV‐DRRs from MV‐DRs with fractal hourglass convolutional network. Electron lett 2018;54:762-4. [DOI: 10.1049/el.2017.4572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
385 Lühr A, von Neubeck C, Pawelke J, Seidlitz A, Peitzsch C, Bentzen SM, Bortfeld T, Debus J, Deutsch E, Langendijk JA, Loeffler JS, Mohan R, Scholz M, Sørensen BS, Weber DC, Baumann M, Krause M; “Radiobiology of Proton Therapy”. "Radiobiology of Proton Therapy": Results of an international expert workshop. Radiother Oncol 2018;128:56-67. [PMID: 29861141 DOI: 10.1016/j.radonc.2018.05.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 13.6] [Reference Citation Analysis]
386 Durante M, Formenti SC. Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway. Front Oncol 2018;8:192. [PMID: 29911071 DOI: 10.3389/fonc.2018.00192] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 13.8] [Reference Citation Analysis]
387 Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunol Rev 2017;280:220-30. [PMID: 29027232 DOI: 10.1111/imr.12568] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
388 Kamran SC, Mouw KW. Applying Precision Oncology Principles in Radiation Oncology. JCO Precis Oncol 2018;2:PO. [PMID: 32914000 DOI: 10.1200/PO.18.00034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
389 Ghandi K, Wang F, Landry C, Mostafavi M. Naked Gold Nanoparticles and hot Electrons in Water. Sci Rep 2018;8:7258. [PMID: 29740110 DOI: 10.1038/s41598-018-25711-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
390 Winter RM, Leibfarth S, Schmidt H, Zwirner K, Mönnich D, Welz S, Schwenzer NF, la Fougère C, Nikolaou K, Gatidis S, Zips D, Thorwarth D. Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients. Radiother Oncol 2018;128:485-91. [PMID: 29747873 DOI: 10.1016/j.radonc.2018.04.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
391 Burmeister JW, Tracey MW, Kacin SE, Dominello MM, Joiner MC. Improving Research in Radiation Oncology through Interdisciplinary Collaboration. Radiat Res 2018;190:1-4. [PMID: 29693501 DOI: 10.1667/RR15023.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
392 Ligtenberg H, Schakel T, Dankbaar JW, Ruiter LN, Peltenburg B, Willems SM, Kasperts N, Terhaard CHJ, Raaijmakers CPJ, Philippens MEP. Target Volume Delineation Using Diffusion-weighted Imaging for MR-guided Radiotherapy: A Case Series of Laryngeal Cancer Validated by Pathology. Cureus 2018;10:e2465. [PMID: 29900085 DOI: 10.7759/cureus.2465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
393 Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. Oncotarget 2018;9:18198-213. [PMID: 29719599 DOI: 10.18632/oncotarget.24797] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
394 Ajdari A, Ghate A, Kim M. Adaptive treatment-length optimization in spatiobiologically integrated radiotherapy. Phys Med Biol 2018;63:075009. [DOI: 10.1088/1361-6560/aab4b6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
395 Zwanenburg A, Löck S. Why validation of prognostic models matters? Radiother Oncol 2018;127:370-3. [PMID: 29598835 DOI: 10.1016/j.radonc.2018.03.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
396 Combs SE, Niyazi M, Adeberg S, Bougatf N, Kaul D, Fleischmann DF, Gruen A, Fokas E, Rödel CM, Eckert F, Paulsen F, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J, Kessel KA. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK). Cancer Med 2018;7:1742-9. [PMID: 29573214 DOI: 10.1002/cam4.1425] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
397 Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. Radiother Oncol 2018;127:12-9. [PMID: 29523409 DOI: 10.1016/j.radonc.2018.02.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
398 Habermehl D. Strahlentherapie bei Weichteilsarkomen der Extremitäten. Trauma Berufskrankh 2018;20:62-67. [DOI: 10.1007/s10039-017-0305-3] [Reference Citation Analysis]
399 Kushner CJ, Hwang WT, Wang S, Solin LJ, Vapiwala N. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. Breast Cancer Res Treat 2018;170:45-53. [PMID: 29488126 DOI: 10.1007/s10549-018-4729-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
400 Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18:313-322. [PMID: 29449659 DOI: 10.1038/nrc.2018.6] [Cited by in Crossref: 542] [Cited by in F6Publishing: 567] [Article Influence: 108.4] [Reference Citation Analysis]
401 Liu Y, Zhang P, Li F, Jin X, Li J, Chen W, Li Q. Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells. Theranostics 2018;8:1824-49. [PMID: 29556359 DOI: 10.7150/thno.22172] [Cited by in Crossref: 157] [Cited by in F6Publishing: 164] [Article Influence: 31.4] [Reference Citation Analysis]
402 Bortfeld TR, Loeffler JS. Three ways to make proton therapy affordable. Nature 2017;549:451-3. [PMID: 28959981 DOI: 10.1038/549451a] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
403 Tao SC, Guo SC, Zhang CQ. Modularized Extracellular Vesicles: The Dawn of Prospective Personalized and Precision Medicine. Adv Sci (Weinh) 2018;5:1700449. [PMID: 29619297 DOI: 10.1002/advs.201700449] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
404 Hechtner M, Krause M, König J, Appold S, Hornemann B, Singer S, Baumann M. Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy – Results of the randomized CHARTWEL trial. Radiotherapy and Oncology 2018;126:283-90. [DOI: 10.1016/j.radonc.2017.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
405 Schakel T, Peltenburg B, Dankbaar JW, Cardenas CE, Aristophanous M, Terhaard CHJ, Hoogduin JM, Philippens MEP. Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose positron emission tomography. Phys Imaging Radiat Oncol 2018;5:13-8. [PMID: 33458363 DOI: 10.1016/j.phro.2017.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
406 Basler L, Andratschke N, Ehrbar S, Guckenberger M, Tanadini-Lang S. Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study. Radiat Oncol 2018;13:10. [PMID: 29357886 DOI: 10.1186/s13014-018-0952-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
407 Bibault JE, Zapletal E, Rance B, Giraud P, Burgun A. Labeling for Big Data in radiation oncology: The Radiation Oncology Structures ontology. PLoS One 2018;13:e0191263. [PMID: 29351341 DOI: 10.1371/journal.pone.0191263] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
408 Inamdar S, Pushpavanam K, Lentz JM, Bues M, Anand A, Rege K. Hydrogel Nanosensors for Colorimetric Detection and Dosimetry in Proton Beam Radiotherapy. ACS Appl Mater Interfaces 2018;10:3274-81. [DOI: 10.1021/acsami.7b15127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
409 Marland JRK, Blair EO, Flynn BW, González-fernández E, Huang L, Kunkler IH, Smith S, Staderini M, Tsiamis A, Ward C, Murray AF. Implantable Microsystems for Personalised Anticancer Therapy. CMOS Circuits for Biological Sensing and Processing 2018. [DOI: 10.1007/978-3-319-67723-1_11] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
410 Wohlfahrt P, Möhler C, Richter C, Greilich S. Evaluation of Stopping-Power Prediction by Dual- and Single-Energy Computed Tomography in an Anthropomorphic Ground-Truth Phantom. International Journal of Radiation Oncology*Biology*Physics 2018;100:244-53. [DOI: 10.1016/j.ijrobp.2017.09.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
411 Ebert N, Tillner F, Baumann M. Advances in Radiation Oncology. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.65428-4] [Reference Citation Analysis]
412 Linge A, Schötz U, Löck S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M; DKTK-ROG. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother Oncol 2018;127:27-35. [PMID: 29295747 DOI: 10.1016/j.radonc.2017.12.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
413 McNabb E, Wong R, Noseworthy MD. Localizing implanted fiducial markers using undersampled co-RASOR MR imaging. Magn Reson Imaging 2018;48:1-9. [PMID: 29229307 DOI: 10.1016/j.mri.2017.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
414 Nenoff L, Priegnitz M, Janssens G, Petzoldt J, Wohlfahrt P, Trezza A, Smeets J, Pausch G, Richter C. Sensitivity of a prompt-gamma slit-camera to detect range shifts for proton treatment verification. Radiotherapy and Oncology 2017;125:534-40. [DOI: 10.1016/j.radonc.2017.10.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
415 Zietman AL. Too Big to Fail? The Current Status of Proton Therapy in the USA. Clin Oncol (R Coll Radiol) 2018;30:271-3. [PMID: 29239732 DOI: 10.1016/j.clon.2017.11.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
416 Cheng M, Durm G, Hanna N, Einhorn LH, Kong FS. Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer? Future Oncol 2017;13:2503-5. [PMID: 29168656 DOI: 10.2217/fon-2017-0405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
417 Lacombe S, Porcel E, Scifoni E. Particle therapy and nanomedicine: state of art and research perspectives. Cancer Nanotechnol 2017;8:9. [PMID: 29213338 DOI: 10.1186/s12645-017-0029-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
418 Gill MR, Jarman PJ, Halder S, Walker MG, Saeed HK, Thomas JA, Smythe C, Ramadan K, Vallis KA. A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator. Chem Sci 2018;9:841-9. [PMID: 29629151 DOI: 10.1039/c7sc03712k] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
419 Georg D, Thwaites D. Medical physics in radiation Oncology: New challenges, needs and roles. Radiother Oncol 2017;125:375-8. [PMID: 29150160 DOI: 10.1016/j.radonc.2017.10.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
420 Bütof R, Gumina C, Valentini C, Sommerer A, Appold S, Zips D, Löck S, Baumann M, Troost EGC. Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Clin Transl Radiat Oncol 2017;7:36-42. [PMID: 29594227 DOI: 10.1016/j.ctro.2017.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
421 Grau C, Høyer M, Poulsen PR, Muren LP, Korreman SS, Tanderup K, Lindegaard JC, Alsner J, Overgaard J. Rethink radiotherapy - BIGART 2017. Acta Oncol 2017;56:1341-52. [PMID: 29148908 DOI: 10.1080/0284186X.2017.1371326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
422 Mönnich D, Thorwarth D, Leibfarth S, Pfannenberg C, Reischl G, Mauz PS, Nikolaou K, la Fougère C, Zips D, Welz S. Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer. Acta Oncol 2017;56:1577-82. [PMID: 28849721 DOI: 10.1080/0284186X.2017.1363910] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
423 De-Colle C, Menegakis A, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Abu Jawad J, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Belka C, Ganswindt U, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D; DKTK-ROG. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. Radiother Oncol 2018;126:125-31. [PMID: 29061496 DOI: 10.1016/j.radonc.2017.10.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
424 Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Krause M, Baumann M, Troost EGC, Löck S, Richter C. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 2017;7:13206. [PMID: 29038455 DOI: 10.1038/s41598-017-13448-3] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 20.2] [Reference Citation Analysis]
425 Wohlfahrt P, Möhler C, Stützer K, Greilich S, Richter C. Dual-energy CT based proton range prediction in head and pelvic tumor patients. Radiother Oncol 2017;125:526-33. [PMID: 29050953 DOI: 10.1016/j.radonc.2017.09.042] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
426 Brandsma I, Fleuren EDG, Williamson CT, Lord CJ. Directing the use of DDR kinase inhibitors in cancer treatment. Expert Opin Investig Drugs 2017;26:1341-55. [PMID: 28984489 DOI: 10.1080/13543784.2017.1389895] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
427 Zhao H, Cheng Y, Dong S, Du J, Gao F, Sun D, Cui J, Ni J, Cai J. Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1. Toxicol Lett 2017;280:116-24. [PMID: 28736328 DOI: 10.1016/j.toxlet.2017.07.891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
428 Kim CK, Yang VW, Bialkowska AB. The Role of Intestinal Stem Cells in Epithelial Regeneration Following Radiation-Induced Gut Injury. Curr Stem Cell Rep 2017;3:320-32. [PMID: 29497599 DOI: 10.1007/s40778-017-0103-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
429 Bokrantz R, Fredriksson A. Necessary and sufficient conditions for Pareto efficiency in robust multiobjective optimization. European Journal of Operational Research 2017;262:682-92. [DOI: 10.1016/j.ejor.2017.04.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
430 Regnier A, Ulbrich J, Münch S, Oechsner M, Wilhelm D, Combs SE, Habermehl D. Comparative Analysis of Efficacy, Toxicity, and Patient-Reported Outcomes in Rectal Cancer Patients Undergoing Preoperative 3D Conformal Radiotherapy or VMAT. Front Oncol 2017;7:225. [PMID: 28979889 DOI: 10.3389/fonc.2017.00225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
431 Stützer K, Jakobi A, Bandurska-Luque A, Barczyk S, Arnsmeyer C, Löck S, Richter C. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes. J Appl Clin Med Phys 2017;18:104-13. [PMID: 28921843 DOI: 10.1002/acm2.12189] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
432 De-Colle C, Yaromina A, Hennenlotter J, Thames H, Mueller AC, Neumann T, Stenzl A, Scharpf M, Fend F, Ricardi U, Baumann M, Zips D, Menegakis A. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity. Radiother Oncol 2017;124:386-94. [PMID: 28919005 DOI: 10.1016/j.radonc.2017.08.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
433 Yaromina A, Granzier M, Biemans R, Lieuwes N, van Elmpt W, Shakirin G, Dubois L, Lambin P. A novel concept for tumour targeting with radiation: Inverse dose-painting or targeting the “Low Drug Uptake Volume”. Radiotherapy and Oncology 2017;124:513-20. [DOI: 10.1016/j.radonc.2017.04.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
434 Rostami A, Bratman SV. Utilizing circulating tumour DNA in radiation oncology. Radiotherapy and Oncology 2017;124:357-64. [DOI: 10.1016/j.radonc.2017.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
435 Thorwarth D. Biologically adapted radiation therapy. Z Med Phys 2018;28:177-83. [PMID: 28869163 DOI: 10.1016/j.zemedi.2017.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
436 Löck S, Perrin R, Seidlitz A, Bandurska-Luque A, Zschaeck S, Zöphel K, Krause M, Steinbach J, Kotzerke J, Zips D, Troost EGC, Baumann M. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging. Radiother Oncol 2017;124:533-40. [PMID: 28843726 DOI: 10.1016/j.radonc.2017.08.010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 14.3] [Reference Citation Analysis]
437 Rodriguez-Ruiz ME, Rodriguez I, Barbes B, Mayorga L, Sanchez-Paulete AR, Ponz-Sarvise M, Pérez-Gracia JL, Melero I. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies. Brachytherapy 2017;16:1246-51. [PMID: 28838649 DOI: 10.1016/j.brachy.2017.06.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
438 Koi L, Löck S, Linge A, Thurow C, Hering S, Baumann M, Krause M, Gurtner K. EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiother Oncol 2017;124:496-503. [PMID: 28807520 DOI: 10.1016/j.radonc.2017.07.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
439 Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN. Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example. Mol Cancer Ther 2018;17:355-67. [PMID: 28802252 DOI: 10.1158/1535-7163.MCT-17-0262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
440 Levy A, Nigro G, Sansonetti PJ, Deutsch E. Candidate immune biomarkers for radioimmunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017;1868:58-68. [DOI: 10.1016/j.bbcan.2017.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
441 Nakashima R, Goto Y, Koyasu S, Kobayashi M, Morinibu A, Yoshimura M, Hiraoka M, Hammond EM, Harada H. UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization. Sci Rep 2017;7:6879. [PMID: 28761052 DOI: 10.1038/s41598-017-06605-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
442 Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting MicroRNAs in Prostate Cancer Radiotherapy. Theranostics 2017;7:3243-59. [PMID: 28900507 DOI: 10.7150/thno.19934] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 7.8] [Reference Citation Analysis]
443 Goto Y, Koyasu S, Kobayashi M, Harada H. The emerging roles of the ubiquitination/deubiquitination system in tumor radioresistance regarding DNA damage responses, cell cycle regulation, hypoxic responses, and antioxidant properties: Insight into the development of novel radiosensitizing strategies. Mutat Res 2017;803-805:76-81. [PMID: 28778421 DOI: 10.1016/j.mrfmmm.2017.07.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
444 Rassamegevanon T, Löck S, Range U, Krause M, Baumann M, von Neubeck C. Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models. Radiother Oncol 2017;124:379-85. [PMID: 28739384 DOI: 10.1016/j.radonc.2017.06.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
445 Lee EJ, Yang SH, Kim KJ, Cha H, Lee SJ, Kim JH, Song J, Chun KH, Seong J. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma. Cancer Res Treat 2018;50:646-57. [PMID: 28724284 DOI: 10.4143/crt.2016.550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
446 Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys 2018;101:274-84. [PMID: 28964588 DOI: 10.1016/j.ijrobp.2017.05.044] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
447 Zschaeck S, Hofheinz F, Zöphel K, Bütof R, Jentsch C, Schmollack J, Löck S, Kotzerke J, Baretton G, Weitz J, Baumann M, Krause M. Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy. Eur J Nucl Med Mol Imaging 2017;44:1813-22. [PMID: 28600646 DOI: 10.1007/s00259-017-3742-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
448 Chen HHW, Kuo MT. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget 2017;8:62742-58. [PMID: 28977985 DOI: 10.18632/oncotarget.18409] [Cited by in Crossref: 115] [Cited by in F6Publishing: 125] [Article Influence: 19.2] [Reference Citation Analysis]
449 Chen H, Zhang W, Zhu G, Xie J, Chen X. Rethinking cancer nanotheranostics. Nat Rev Mater 2017;2:17024. [PMID: 29075517 DOI: 10.1038/natrevmats.2017.24] [Cited by in Crossref: 654] [Cited by in F6Publishing: 692] [Article Influence: 109.0] [Reference Citation Analysis]
450 Bagher-Ebadian H, Siddiqui F, Liu C, Movsas B, Chetty IJ. On the impact of smoothing and noise on robustness of CT and CBCT radiomics features for patients with head and neck cancers. Med Phys 2017;44:1755-70. [PMID: 28261818 DOI: 10.1002/mp.12188] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
451 Apolle R, Rehm M, Bortfeld T, Baumann M, Troost EGC. The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis. Clin Transl Radiat Oncol 2017;3:1-8. [PMID: 29658006 DOI: 10.1016/j.ctro.2017.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
452 Winter M, Dokic I, Schlegel J, Warnken U, Debus J, Abdollahi A, Schnölzer M. Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions. Mol Cell Proteomics 2017;16:855-72. [PMID: 28302921 DOI: 10.1074/mcp.M116.066597] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
453 Durante M, Orecchia R, Loeffler JS. Charged-particle therapy in cancer: clinical uses and future perspectives. Nat Rev Clin Oncol 2017;14:483-95. [DOI: 10.1038/nrclinonc.2017.30] [Cited by in Crossref: 234] [Cited by in F6Publishing: 241] [Article Influence: 39.0] [Reference Citation Analysis]
454 Luo Y, El Naqa I, McShan DL, Ray D, Lohse I, Matuszak MM, Owen D, Jolly S, Lawrence TS, Kong FS, Ten Haken RK. Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis. Radiother Oncol 2017;123:85-92. [PMID: 28237401 DOI: 10.1016/j.radonc.2017.02.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
455 Zschaeck S, Löck S, Leger S, Haase R, Bandurska-Luque A, Appold S, Kotzerke J, Zips D, Richter C, Gudziol V, Schreiber A, Zöphel K, Baumann M, Krause M. FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy. Radiother Oncol 2017;122:437-44. [PMID: 28222892 DOI: 10.1016/j.radonc.2017.01.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
456 Habermehl D, Habl G, Eckstein HH, Meisner F, Combs SE. [Radiotherapeutic management of lymphatic fistulas : An effective but disregarded therapy option]. Chirurg 2017;88:311-6. [PMID: 28083600 DOI: 10.1007/s00104-016-0352-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
457 Avuzzi B, Valdagni R. Bone Metastases from Prostate Cancer: Radiotherapy. Bone Metastases from Prostate Cancer 2017. [DOI: 10.1007/978-3-319-42327-2_14] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
458 Linge A, Löck S, Krenn C, Appold S, Lohaus F, Nowak A, Gudziol V, Baretton GB, Buchholz F, Baumann M, Krause M. Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy. Clin Transl Radiat Oncol 2016;1:19-26. [PMID: 29657990 DOI: 10.1016/j.ctro.2016.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
459 Kunz-Schughart LA, Dubrovska A, Peitzsch C, Ewe A, Aigner A, Schellenburg S, Muders MH, Hampel S, Cirillo G, Iemma F, Tietze R, Alexiou C, Stephan H, Zarschler K, Vittorio O, Kavallaris M, Parak WJ, Mädler L, Pokhrel S. Nanoparticles for radiooncology: Mission, vision, challenges. Biomaterials 2017;120:155-84. [PMID: 28063356 DOI: 10.1016/j.biomaterials.2016.12.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 9.7] [Reference Citation Analysis]
460 Jentsch C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Krause M, Zips D, Troost EG, Löck S, Kotzerke J, Steinbach J, Thames H, Baumann M, Beuthien-baumann B. Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours. Radiotherapy and Oncology 2016;121:447-52. [DOI: 10.1016/j.radonc.2016.07.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
461 Valdes G, Luna JM, Eaton E, Simone CB 2nd, Ungar LH, Solberg TD. MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine. Sci Rep 2016;6:37854. [PMID: 27901055 DOI: 10.1038/srep37854] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
462 Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol 2016;121:364-73. [PMID: 27913065 DOI: 10.1016/j.radonc.2016.11.008] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 12.3] [Reference Citation Analysis]
463 Acharya CR, Owzar K, Horton JK, Allen AS. Exploiting expression patterns across multiple gene isoforms to identify radiation response biomarkers in early-stage breast cancer patients.. [DOI: 10.1101/086322] [Reference Citation Analysis]
464 Ngwa W, Boateng F, Kumar R, Irvine DJ, Formenti S, Ngoma T, Herskind C, Veldwijk MR, Hildenbrand GL, Hausmann M, Wenz F, Hesser J. Smart Radiation Therapy Biomaterials. Int J Radiat Oncol Biol Phys 2017;97:624-37. [PMID: 28126309 DOI: 10.1016/j.ijrobp.2016.10.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
465 Ireland R, Tahir B, Wild J, Lee C, Hatton M. Functional Image-guided Radiotherapy Planning for Normal Lung Avoidance. Clinical Oncology 2016;28:695-707. [DOI: 10.1016/j.clon.2016.08.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
466 Overgaard J, Jovanovic A, Godballe C, Grau Eriksen J. The Danish Head and Neck Cancer database. Clin Epidemiol 2016;8:491-6. [PMID: 27843342 DOI: 10.2147/CLEP.S103591] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
467 Marvaso G, Vischioni B, Jereczek-Fossa BA, Ciardo D, Fossati P, Giandini T, Morlino S, Carrara M, Romanelli P, Russi E, Valvo F, Valdagni R, Orecchia R. Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey. Radiol Med 2017;122:140-5. [PMID: 27770265 DOI: 10.1007/s11547-016-0699-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
468 Choi H, Park J, Ko SY, Park S, Cho S, Jung W, Park YK, Kang JS. Development of a robotic patient positioning system with a wide beam-angle range for fixed-beam particle therapy. Journal of the Korean Physical Society 2016;69:1271-1285. [DOI: 10.3938/jkps.69.1271] [Reference Citation Analysis]
469 Yi X, Chen L, Zhong X, Gao R, Qian Y, Wu F, Song G, Chai Z, Liu Z, Yang K. Core–shell Au@MnO2 nanoparticles for enhanced radiotherapy via improving the tumor oxygenation. Nano Res 2016;9:3267-78. [DOI: 10.1007/s12274-016-1205-8] [Cited by in Crossref: 122] [Cited by in F6Publishing: 123] [Article Influence: 17.4] [Reference Citation Analysis]
470 Hill RP. The changing paradigm of tumour response to irradiation. Br J Radiol 2017;90:20160474. [PMID: 27416998 DOI: 10.1259/bjr.20160474] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
471 Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016;5:e1214790. [PMID: 27757313 DOI: 10.1080/2162402X.2016.1214790] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
472 Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM. Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. Clin Cancer Res 2016;22:3138-47. [PMID: 27154913 DOI: 10.1158/1078-0432.CCR-16-0069] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
473 Baumann M, Overgaard J. Bridging the valley of death: The new Radiotherapy & Oncology section “First in man – Translational innovations in radiation oncology”. Radiotherapy and Oncology 2016;118:217-9. [DOI: 10.1016/j.radonc.2016.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
474 Olcina MM, Kim R, Giaccia AJ. The Role of Hypoxia in Radiation Response. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment 2016. [DOI: 10.1007/978-3-319-45594-5_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
475 Linge A, Dubrovska A, Baumann M, Krause M. The Role of Cancer Stem Cells in Tumour Radioresponse. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment 2016. [DOI: 10.1007/978-3-319-45594-5_3] [Reference Citation Analysis]